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ABSTRACT OF THE DISSERTATION

Mechanisms for Osteoblast and Osteocyte Initiation and Sustainment of Bone Formation in
Young-Adult and Aged mice
by
Taylor Lynn Harris
Doctor of Philosophy in Biomedical Engineering
Washington University in St. Louis, 2021
Professor Matthew Silva, Chair

The cellular mechanisms for loading-induced bone formation, from osteocyte mechanosensation to osteoblast-directed bone formation, are not well understood. Elucidating these
mechanisms and identifying any processes that are disrupted in aged mice can aide in the
development of new anabolic drugs for treating diseases like osteoporosis. This thesis begins by
investigating the genes expressed by osteocytes following loading at an early mechanosensitive
(4-hr) timepoint, and later at a bone-forming (day 5) timepoint. We demonstrated increases in
Ngf and Wnt1 in osteocyte-enriched intracortical bone by laser capture microdissection and
microarray analysis. These results were important in demonstrating the presence of Ngf in
osteocytes, and in suggesting the role of Wnt1 as a potential signaling molecule between
osteocytes and osteoblasts which are currently unknown. Next, we investigated the effects of
osteocyte-signaling on osteoblasts by studying the osteoblast differentiation stages at the bone
surface and role of proliferation following loading-induced bone formation. We utilized lineage
tracing with inducible Osx- and Dmp1-expressing reporter mice to evaluate the contribution of
these cells to bone-forming surfaces at days 8 and 12 following the onset of loading. EdU was
xiii

administered to mice via drinking water from the start of loading until sacrifice to identify any
cells that arose via proliferation. Previously, it was shown that Osx-expressing cells are activated
following loading to initiate bone formation 5 days following the onset of loading [1]. We
expanded these results by showing that Dmp1-expressing cells make up a large portion of the
initial response to loading and become nearly depleted from the bone surface on days 8 and 12,
especially in cases of rapid bone formation (higher stimulation). Our experiments evaluating
bone formation at day 12 following the onset of loading also investigated age effects, comparing
5 mo and 22 mo mice. We demonstrated that similar levels of bone formation occurred at both
ages, and similar mechanisms were utilized by young-adult and aged mice. Pre-existing Dmp1expressing cells decreased at the bone surface in young-adult and aged mice to a similar degree.
However, pre-existing Osx-expressing cells were not decreased with loading in aged mice, while
a decrease occurred in young-adults. Thus, pre-existing preosteoblasts continue to sustain the
bone formation response at day 12 in aged mice, but less differentiated cells perform this role in
young-adult mice. Lastly, the proliferative response was shown to be dose dependent with more
proliferation occurring in cases of more rapid bone formation, and no effect was found with age
at day 12.

xiv

1Chapter 1: Overview of Bone Formation
1.1 Bone Structure and Function
The skeleton is composed primarily of long bones (e.g., limbs) formed through a process
called endochondral ossification and flat bones (e.g., skull) formed through intramembranous
ossification. Developmental studies investigating these processes have been instrumental in our
understanding of bone formation. Endochondral ossification begins with a cartilage template
formed by chondrocytes that are subsequently vascularized and remodeled to form a long bone
with a center composed of marrow, fat, and thin rods/plates, or trabeculae, and a thick, dense
outer shell composed of mineralized compact, or cortical, bone. In contrast, intramembranous
ossification is initiated by the aggregation of osteoblast progenitor cells that differentiate into
mature osteoblasts and form bone matrix. This matrix is also remodeled but does not require a
cartilaginous template. The resulting bone is composed of two cortical plates with an inner
region of marrow, fat, and trabeculae (or cancellous bone). [2]
Surrounding cortical bone on the exterior is the periosteum, and on the interior is the
endosteum. The periosteum contains progenitor cells in the inner cambium layer, and the outer
fibrous layer contains more blood vessels and nerves than reside in the dense cortical bone
compartment [2]. These features contribute to nutrient support, fracture repair and response to
external stimuli [3]–[6]. The endosteum is adjacent to marrow which contains many
mesenchymal stem cells and blood vessels [2]. Differences in the periosteum and endosteum are
not well known, but advances in technology have begun to reveal many differences in
composition and responses to external stimuli [3], [7]. For example, Turner et al. showed that the
periosteal surface was more proliferative in response to mechanical loading [8], Cabahug1

Zuckerman et al. showed a delay of 2 days in the endosteal proliferative response to mechanical
loading [7]. Others have also observed differences in responses of the cancellous and cortical
bone to various stimuli [9], [10].
Blood vessels within the periosteum and marrow connect with cells within cortical bone
through the Haversian system [2]. This system is composed of concentric layers of bone, called
osteons, that surround canals containing blood vessels and nerves (Figure 1.1) [2]. The osteon
layers are termed lamellae, and contain one of the four types of bone cells: the osteocyte [2]. The
osteocyte is the most abundant cell type in bone and resides in mineralized cortical bone inside
of spaces called lacunae [11]. These cells have long cellular processes, or dendrites, that extend
from the cell body and connect with other osteocytes and cells on the bone surface [11].
Osteocytes are well known for their role in sensing external forces applied to the body via
changes in fluid flow surrounding their cell body and processes, and in regulation of phosphate
metabolism and mineral homeostasis (e.g. lactation) [11].

Figure 1.1: Overview of bone structure. (A) Long bone structure and (B) microstructure of cortical (or compact)
bone. Figure adapted from Robles-Linares et al. [13].
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The other major cell types in bone include osteoblasts, bone lining cells, and osteoclasts.
Osteoblasts reside on the bone surface and are the cells responsible for secreting type 1 collagen,
the primary component of the organic phase of bone matrix, which is called osteoid, before it
becomes mineralized [14]. They also secrete alkaline phosphatase and osteocalcin which aide in
mineralization [14]. Osteoblasts descend from progenitors classically called mesenchymal stem
cells (MSCs) [15], but now are also known as skeletal stem cells (SSCs) [16]. Fully
differentiated osteoblasts have one of three cell fates; become a bone lining cell or osteocyte, or
undergo apoptosis [14]. Bone lining cells are quiescent, inactive cells at the bone surface that are
very thin in morphology [14]. These cells have been shown to reactivate on the bone surface in
response to parathyroid hormone (PTH) and sclerostin antibody [17], [18]. In contrast to these
cells, osteoclasts play the primary role in bone removal, or resorption. These cells descend from
a hematopoietic monocyte-macrophage lineage, and have many similarities to immune cells [19].
Osteoclasts are important for bone remodeling, in which they resorb bone followed by
osteoblast-directed bone formation [14]. When this system is out of balance, bone loss can occur,
causing skeletal fragility and increased risk of fracture [14].
Bone serves as a protective structure for vital organs and a support system for the body:
thus, mechanics play an important role in bone function and health. Bone formation and
resorption occurs in specific regions of growing bone based on its mechanical strain environment
to produce a system ideally suited for the typical loads applied to each bone [14]. One of the
most clear examples of this process is in the alignment of trabecular struts in the proximal femur
with the direction of principal strains (Figure 1.2) [14], [20].
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Figure 1.2: Example of orientation of trabecular struts in the direction of principal strains in the femur. (AD) Longitudinal section of the proximal femur of a (A) 31 year old, (B) 3 year old, (C) 1 year old, and a (D)
newborn. (E) Sagittal section of a 5 year old proximal femur. Note the isotropic orientation of trabeculae in younger
bones compared to the organization of trabeculae in older individuals. Image adapted from Wolff [20].

Bone also serves an important role as an endocrine organ. Osteocytes are the largest
source of fibroblast growth factor 23 (FGF-23) in the body, which is important in phosphate
metabolism and kidney function [14], [21]. Another interesting function of bone is in mineral
storage and homeostasis. During lactation, increased secretion of parathyroid hormone related
protein (PTHrP) stimulates osteocyte perilacunar remodeling, whereby osteocytes resorb their
surrounding matrix to release calcium during increased demand. In just 6 months, lactating
4

women lose 3-8% of their bone mineral density [22]–[24]. During this process, osteocytes
express many of the factors expressed by osteoclasts to resorb their matrix including Tartrate
Resistant Acid Phosphatase (TRAP), and Cathepsin K [23].

1.2 The Role of Osteocytes in Mechanotransduction
The structure of bone develops via adaptation to the mechanical strain environment placed
upon the body. Once skeletal maturity is attained, bone continues responding to its mechanical
environment. In cases of greater demand for bone strength, bone mass is increased, and in cases
where demand is low, bone mass is decreased. An example of this is in professional tennis
players, where bone mineral content was found to be increased 12-27% more in the playing arm
of men 30 years old [25]. Interestingly, these exercise-related benefits are maintained throughout
life [26]. On the other hand, reductions in mechanical loads, like in microgravity conditions
during spaceflight, cause dramatic decreases in bone mineral density of up to 1.5% per month in
the hip [27]. Another example of this bone loss is in cases of bedrest where bone mineral density
at the hip is diminished by up to 3.8% after 3 months [28].
The adaptability of the skeleton is controlled by mechanotransduction. This process is
orchestrated by osteocytes embedded in the mineralized matrix of cortical bone. The osteocyte
senses mechanical loading by changes in fluid flow through the narrow canals surrounding their
cell bodies and processes [29]. Evidence exists suggesting that tethers attaching the osteocyte
processes to the perilacunar wall are the main sensory mechanism that induces downstream
molecular signaling in the osteocyte [30]–[32]. However, others have shown the attachments of
osteocyte cell bodies to the extracellular matrix as primary mechanism. Other lines of evidence
also point towards primary cilia of osteocytes for playing a key role in mechanosensation in bone
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[33]. Interestingly, primary cilia of osteoblasts have also been shown to be involved in
mechanotransduction [34].
Consensus has not been reached on how osteocytes and/or osteoblasts sense changes in
loading, but once stimulated, calcium signaling is one of the first molecular events to occur [35],
by activation of Piezo1 channels [29], [36], and potentially TRPV4 [37], [38]. Connexin43 has
also been identified as an important gap junction channel activated following loading, allowing
cell-cell communication between osteocytes and osteoblasts [39]. Other initial responses include
osteocyte release of nitric oxide, adenosine triphosphate, and prostaglandin E2, and increased
expression of Cox-2 [37], [40], [41]. Finally, Wnt signaling is recognized as one of the most
important downstream pathways effected during mechanotransduction [42]. This is mediated by
osteocytic downregulation of a Wnt signaling inhibitor, SOST [42]. The increased Wnt signaling
that subsequently occurs in osteoblasts drives osteoblast proliferation and differentiation which
leads to increased bone formation [42].
Sensitivity to different mechanical stimuli have been thoroughly studied. Lanyon et al.
showed bone responds to dynamic strain magnitude [43], [44]. It has also been shown that
increasing the number of loading cycles beyond a small number (~50) does not significantly
increase bone formation rate [44], [45]. The importance of strain rate has been demonstrated, and
was shown to increase bone formation rate [46]. Strain magnitude and frequency have also been
shown to influence the number of osteocytes responding to loading [35].

1.3 The Role of Osteoblasts in Bone Formation
Osteoblasts originate from mesenchymal stem cells that are capable of giving rise to
osteoblasts, chondrocytes, or adipocytes (Figure 1.3). Runx2 is a crucial transcription factor
6

responsible for driving the cell to the osteoblast lineage [15]. Next in the differentiation cascade
is the transcription factor, Osterix (Osx), which is necessary for bone formation in development
[15]. Runx2 and Osx expression are typically associated with the preosteoblast stages, where
cells maintain their ability to proliferate [15], [47]. In the case of Osx, osteoblast lineage cells
can continue to express this factor through the osteocyte stage [1]. Further differentiation
decreases proliferative ability, and cells begin to express type 1 collagen [47]. Finally, mature
osteoblasts express osteocalcin which enhances calcium binding and mineralization [14], [47].
At this point, the mature osteoblast is capable of mineralizing its matrix and differentiating into
an osteocyte. This requires Dentin Matrix Protein 1 (Dmp1) expression, which begins at a late
osteoblast stage [48]. Once the cell begins embedding, E11 is expressed which initiates dendrite
formation, and eventually FGF-23, PHEX, MEPE, and SOST are expressed at high levels in the
mature osteocyte [48].

Figure 1.3: Transcription factors and proteins expressed throughout osteoblast differentiation. Figures
adapted from Maes et al. [47].

Additionally, recent work on earlier markers have revealed that Prx1 is expressed by
osteoprogenitors that maintain chondrogenic potential [49]. Prx1 cells co-expressing Sca1, a
7

MSC marker, express low levels of Runx2 and as Sca1 expression diminishes, Runx2 expression
is enhanced [50]. It has also been shown that Prx1 is not expressed by Osx+ cells, suggesting that
it is turned off at later stages [50]. Leptin receptor (LepR) and α-smooth muscle actin (αSMA)
are two other markers of mesenchymal stem cells [51], [52]. Interestingly, bone lining cells may
express earlier osteoblast markers including Sca1 and LepR, retain the ability to proliferate, and
reside on the bone surface for up to 6 months [53].
Osteoblasts can form bone at different rates. During physiological loading
environments, bone is usually formed in a highly organized manner and is densely mineralized
[14], [54]. This type of bone is called lamellar bone. Woven bone formation occurs when bone is
laid down rapidly, due to high strains applied to the bone or in response to injury [54]. This bone
is less mineralized, more cellular and vascularized, and has a high rate of remodeling [14], [55].
These types of bone formation have different transcriptional profiles [55].
With mice, as well as other small animals, investigators have been able to develop
loading devices that can apply load to the hind- or fore- limb in a non-invasive, controlled and
consistent manner. Earlier studies utilized 4-point bending, but this method applies contact
directly to the bone surface near sites of analysis, potentially causing an injury response [8].
Currently, uniaxial tibial or ulnar compression are the primary mechanisms for studying
mechanical loading-induced bone formation in vivo (Figure 1.4) [56]. This system holds the
ankle and knee in place while applying a force-controlled load in the direction of physiological
loading [56].
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Figure 1.4: Diagram of axial tibial loading in the mouse tibia. Image adapted from De Souza et al. [56].

1.4 Mouse Models in Bone
In order to study bone formation, mouse models are typically used. Mouse bones respond
to mechanical forces similar to human bone. However, one major difference in mice is the lack
of the Haversian system [57]. Mice do not have well-defined osteons, likely due to their smaller
size and the decreased need for additional vascular canals. Importantly for studying age-related
bone diseases, mice experience cortical thinning and increased cortical porosity with age, similar
to humans [57]. They also experience a diminished response to mechanical loading [58]. The
lifespan of C57Bl/6 mice is about 28 months, where 50% survivorship occurs. This corresponds
to about 69 years for humans [59]. Skeletal maturity is reached around 5 months of age,
equivalent to ~20-30 years old for humans [59].
Several mouse models exist to aide in studying osteoblasts and osteocytes in vivo during
bone formation. Specifically, the Cre-loxP system has been extensively used (Figure 1.5). In this
system, expression of the Cre enzyme is driven by a tissue specific promoter. For bone, many
9

promoters have been used to target cells earlier or later in the osteoblast lineage, including:
Gremlin1 (Grem1), LepR, Nestin (Nes) αSMA, Prx1, Runx2, Osx, Col1a1, Ocn, Dmp1, and
Sost. When the promoter is active in a particular cell, the Cre enzyme is transcribed and cuts
DNA at specific LoxP sites that surround a stop codon. In the case of reporter mice, once the
stop codon is removed, the DNA encoding a reporter protein (LacZ or TdTomato, the latter used
in the popular Ai9 mouse) is transcribed. This system was further modified to be inducible by
addition of a modified estrogen receptor ligand-binding domain (ERt) to the Cre locus. Now,
when the promoter is active in the cell, and the Cre-ERt domain is transcribed, the protein
remains in the cytoplasm of the cell. Only upon administration of tamoxifen (TAM), a synthetic
estrogen receptor ligand, does the Cre enzyme translocate to the nucleus and cleave the LoxP
sites. In some cases, the Cre-ERt may translocate in the absence of TAM, a phenomenon known
as “leakiness”. Upon cleavage of the stop codon, the DNA is permanently changed and the cell,
along with its progeny, will continue to express the reporter protein. This systems can be used to
knock out particular genes from specific cells or to perform lineage tracing studies (Figure 1.6).
[47]
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Figure 1.5: The inducible Cre -loxP system is driven by active tissue-specific promoters and tamoxifen. In
bone, several different osteoblast promoters can be used to target subpopulations. Upon TAM administration, the
Cre-ERt enzyme translocates to the nucleus where it cleaves the stop codon and allows expression of a reporter
protein (Rosa26 or TdTomato/Ai9). Image adapted from Maes et al. [47].

Studies using reporter mice have shown that Grem1, LepR, Nes, and αSMA mark MSCs
in vivo. These cells have osteo- and chondro- progenitor cell potential. Grem1 is expressed by
osteochondroreticular stem cells in the bone marrow [60]. The Grem1-Cre-ERT;Ai9 mouse
showed some expression in a few periosteal cells and osteocytes approximately 12 months
following tamoxifen administration in adult mice, indicating their osteogenic potential [60].
These cells represent a source of early stem cells that are recruited for fracture repair [60]. LepR
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and Nes reporters also mark mesenchymal stem cells [60]. These cells surround marrow
sinusoids (perisinusoidal), and have some pluripotent ability, but it is unclear if they truly
represent a mesenchymal stem cell capable of postnatal proliferation and osteogenic potential
[60]. The Prx1-Cre-ER-GFP mouse shows expression in the periosteum, but not in osteocytes in
4 mo mice following 5 days of tamoxifen administration [34]. The αSMA-Cre-ER;Ai9 mouse
shows expression in the periosteum, but not overlapping with Col2.3GFP+ cells which are more
mature and reside closer to the bone surface in adult mice [61]. Matthews et al. showed that these
cells expand by day 2 following fracture in the periosteum, and contribute significantly to the
fracture callus by day 6 [61].
Yang et al. showed with several reporter mice that LepR expressing cells also express
low levels of Runx2, but as Runx2 expression increases, LepR expression diminishes while Osx
expression increases [62]. They also showed that the 2.3kb Col1a1 reporter marks fewer cells
than Osx, suggesting that Osx marks cells beginning at a slightly more pre-osteoblastic stage
[62]. In 5 mo and 12 mo mice, Zannit et al. showed that the Osx-Cre-ERT2;Ai9 reporter marks
>95% of the bone surface cells, in addition to osteocytes [1]. In mice, two reporters for Col1a1
exist. The 2.3 kbCol1a1 mouse marks differentiated osteoblasts, while the 3.6kb promoter marks
cells at earlier stages [63]. Kalajzic et al. showed, in 5 mo mice, that the 2.3kb Col1a1 promoter
is expressed in osteoblasts and lining cells but not periosteal fibroblasts, while the 3.6kb Col1a1
promoter drives expression in osteoblasts and lining cells in addition to periosteal fibroblasts as
well as dermal fibroblasts, smooth muscle cells, and connective tissue [63].
Finally, mature osteoblasts and osteocytes are marked by Ocn, Dmp1, and Sost reporters.
Ocn-Cre-ERT2 drives reporter expression in 10 week old mice in the periosteum, cortical bone
and endosteum, although expression was low, especially on the periosteum [17], [64]. In 3 mo
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Dmp1-Cre-ERT2;Ai9 mice, osteocytes and some surface cells in the ulna and radius were
expressing the promoter [65]. Others also show expression of the inducible Dmp1 reporter in
osteocytes and mature osteoblasts in younger mice [66], [67]. A Sost-Cre-ERT2;Ai9 reporter
was recently developed, showing improved specificity to osteocytes than other models. In this
mouse, no osteoblasts were identified expressing the Sost promoter [68]. However, with age
(>6mo) a phenotype of enlarged and weaker muscle was apparent [68].

Figure 1.6: Overview of several important osteoblast lineage reporters. (A) Prx1-Cre-ER-GFP cells (brown) are
identified in the periosteum of ulnae, but not in the osteocytes in 4 mo mice. TAM was administered for 5 days with
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follow-up doses the following week before sacrifice. Image adapted from Moore et al. [34]. (B) αSMA-CreERT2;Ai9 (red) cells are identified in the periosteum, but not on the bone surface where Col1(2.3)-GFP cells (green)
can be seen in the femur. TAM was injected and bones evaluated 2 days later in 3-5 mo mice. Image adapted from
Matthews et al. [61]. (C-E) 5-7 week old mice were given TAM via chow for about 2 weeks during which they also
received PTH for 10 days to allow visualization of some distinct populations in the femur. Images adapted from
Yang et al. [62]. (C) Expression of LepR-Cre;Ai9 (red) can be seen in low expressing Runx2-GFP (green) cells. (D)
Osx-Cre-ERT2;Ai9 (red) cells label fewer cells than the Runx2-GFP reporter, but significant overlap can be seen.
(E) Col1(2.3)-GFP (green) marks a more mature population compared to the Osx reporter (red). (F) Osx-CreERT2;Ai9 in 5 mo mice showing osteoblasts and osteocytes labeled in the tibia of non-loaded and loaded limbs.
Mice received TAM for 5 days followed by a 3 week clearance prior to loading. Image adapted from Zannit et al.
[1]. (G) Tibias from 10 week old Ocn-Cre-ERT2;Ai9 mice sacrificed 2 days after a single dose of TAM. Image
adapted from Kim et al. [17]. (H) Cortical and cancellous bone in 4 week old Dmp1-Cre-ERT2;Ai9 mice sacrificed
2 days after a single dose of TAM. Image adapted from Kalajzic et al. [66].

1.5 Goals of the Dissertation
The first goal of this dissertation is to investigate the response of osteocytes to loading
induced bone formation at an early mechano-sensitive timepoint and later at a bone-forming
timepoint. We expect to identify osteocyte-specific genes that may play important roles in the
initiation and sustainment of osteoblast driven bone formation. We will also use the inducible
Cre-LoxP system in osteoblast reporter mice to investigate the contribution of preosteoblasts and
mature osteoblasts to loading induced bone formation at a relatively early timepoint during
active bone formation and at a later timepoint to elucidate any cells that may be important for
initiating and sustaining bone formation. The incidence of proliferation will also be determined
through these experiments. The last goal of this dissertation will be to determine if the lineage
and proliferative capacity of cells contributing to bone formation is different in aged mice to
discover any potential mechanisms for the diminished responsiveness of aged mice to loading.
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2Chapter 2: Gene Expression of Intracortical
Bone Demonstrates Loading-Induced
Increases in Wnt1 and Ngf and Inhibition
of Bone Remodeling Processes
*Previously published in Bone [69]

2.1 Abstract
Osteocytes are the primary mechanosensitive cells in bone. However, their location in
mineralized matrix has limited the in vivo study of osteocytic genes induced by mechanical
loading. Laser Capture Microdissection (LCM) allows isolation of intracortical bone (Intra-CB),
enriched for osteocytes, from bone tissue for gene expression analysis. We used microarray to
analyze gene expression from mouse tibial Intra-CB dissected using LCM 4 hours after a single
loading bout or after 5 days of loading. Osteocyte enrichment was supported by greater
expression of Sost, Dmp1, Phex, and Mepe in Intra-CB regions vs. Mixed regions containing
periosteum and muscle (fold-change (FC) = 3.4, 2.2, 4.6, 3.0, respectively). Over 150
differentially expressed genes (DEGs) due to loading (loaded vs. contralateral control) in IntraCB were found on Day 1 and Day 5, but only 10 genes were differentially expressed on both
days, including Ngf (Day 1 FC= 13.5, Day 5 FC=11.1) and Wnt1 (Day 1 FC=1.5, Day 5
FC=5.1). The expression of Ngf and Wnt1 within Intra-CB was confirmed by in situ
hybridization, and a significant increase in number of Wnt1 mRNA molecules occurred on day 1.
We also found changes in extracellular matrix remodeling with Timp1 (FC=3.1) increased on day
1 and MMP13 (FC=0.3) decreased on day 5. Supporting this result, IHC for osteocytic MMP13
demonstrated a marginal decrease due to loading on day 5. Gene Ontology (GO) biological
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processes for loading DEGs indicated regulation of vasculature, neuronal and immune processes
while cell-type specific gene lists suggested regulation of osteoclast, osteoblast, and endothelial
related genes. In summary, microarray analysis of microdissected Intra-CB revealed differential
regulation of Ngf, Wnt1, and MMP13 due to loading in osteocytes.

2.2 Introduction
Bone mass is regulated by mechanical loading. Bone loss occurs with conditions like bed
rest due to decreased loads on the skeleton [70], while increased skeletal loads can increase bone
mass [71]–[73]. These load-adaptive changes are controlled at the cellular level by bone forming
osteoblasts, bone resorbing osteoclasts, and mechano-sensitive osteocytes. The importance of
osteocytes as the primary mechanosensitive cell in bone has been well described [74]–[76].
Osteocytes make up 90-95% of the cells within bone and are well distributed in a network of
dendrites and cell bodies [11], making them efficient at sending signals to osteoblasts at the bone
surface. Their position within the bone lacunocanalicular (LCN) network allows them to sense
and respond to changes in loading. Mechanisms whereby osteocytes sense and respond to
loading have been described, including calcium signaling [77] [35] and release of nitric oxide
(NO) and prostaglandins (COX-2), which are critical for loading-induced bone formation [40],
[78]. However, the molecules produced by osteocytes that may signal to osteoblasts (and other
cells) to regulate bone formation following mechanical loading are still largely unknown [79].
qPCR and RNAseq analysis have substantially increased our understanding of genes
expressed by cells within bulk bone tissue following loading. These findings have demonstrated
early downregulation of Sost [9] and upregulation of Wnt1 [9], [80], supporting an array of
evidence for the importance of Wnt signaling in mechanotransduction [81]–[83]. Sclerostin
downregulation due to loading has been localized to osteocytes by IHC [84]. Wnt1 is upregulated
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in MLOY4 osteocytes in response to fluid-flow shear stress [36], but whether osteocytes
upregulate Wnt1 expression due to in vivo loading is unclear. Another gene upregulated in bulk
bone tissue by loading is Ngf [9], [80]. Tomlinson et al. showed that loading increased NgfEGFP expression in osteoblasts, but not osteocytes, and that depletion of Ngf attenuated Wnt
signaling in osteocytes [85]. These latter findings demonstrate the complex interplay between
different cell types in bone mechanotransduction.
Bulk bone tissue, processed by removing muscle and marrow, is thought to represent a
predominately osteocyte enriched tissue, but remaining active osteoblasts on the surfaces of
cortical and cancellous bone also contribute to gene expression results [86]. Thus, it is difficult to
ascribe changes in gene expression in bulk bone samples to osteocytes versus osteoblasts, or
even to other bone-resident cells (e.g., endothelial, nerve). Laser Capture Microdissection (LCM)
is a technique used to isolate specific regions from tissue sections for a more homogeneous cell
population. Others have used LCM to confirm osteocyte-specific knock down of genes in
transgenic mouse models [65], and to analyze gene expression in osteocytes following drug
administration in rats [87], [88]. However, no previous work has extensively analyzed gene
expression of laser microdissected osteocyte-enriched tissue in mouse bone.
While LCM allows separation of intracortical osteocytes from surface osteoblasts for gene
expression analysis, difficulty obtaining high concentration and high quality RNA from mouse
tissue has limited its use for whole-transcriptome analysis. In particular, RNAseq methods
require greater mass (~ 1 ng) and quality of RNA than may be feasible with LCM of mouse
bone. Alternatively, some contemporary microarray methods, developed for use on clinical
isolates and whole blood samples that are typically degraded and low in concentration [26]–[28],
[29], may require as little as 100 pg of RNA. Mouse microarrays enable quantitative assessment
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of over 20,000 genes representing the majority of well-known/annotated transcripts in the mouse
genome.
We utilized mouse tibial loading followed by LCM to isolate intracortical bone (Intra-CB)
regions and microarray analysis to discover genes that are regulated by loading in osteocyteenriched samples. We contrasted the expression in the Intra-CB region with a region containing
Mixed tissues (bone, periosteum, muscle). We identified genes specific to Intra-CB regulated by
loading, performed pathway analysis on DEG lists and investigated loading effects in cell-type
specific gene lists.

2.3 Methods
2.3.1 Mice and Mechanical Loading
A total of 27 female C57Bl/6NCrl mice were obtained from Charles River and aged to 5
months old. Animals were kept on a 12-hour light/dark cycle and allowed to feed freely on chow
containing 20% protein and 5% fat (PicoLab Rodent Diet 20, LabDiet). Mouse strain and sex
were chosen for comparison to recently published gene expression studies [80]. Because female
C57BL/6 mice are skeletally mature at 5 months [93], they provide a good representation of
mechanical loading-induced changes to gene expression in young adults without the confounding
effects of growth. Seventeen (17) mice were designated for laser capture microdissection, and 10
for histology.
Axial compression (Electropulse 1000, Instron) was applied to the right hindlimb while
mice were under 3% isofluorane. Each loading bout was 60 cycles of a 4 Hz sinusoidal
waveform with peak force of -8 N. This force induces a maximal compressive strain magnitude
of -2200 µε (1200 µε peak tensile strain), known to induce lamellar bone formation in young18

adult C57Bl/6 female mice [58], [94]. A pre-load of -0.5 N was used for stability of the limb in
the device. The contralateral limb was used as a non-loaded control. Following loading, 0.1
mg/kg of buprenorphine was injected subcutaneously for pain management and mice were
returned to normal cage activity. Mice were euthanized by CO2 asphyxiation at timepoints
described below. All animal experiments were approved by the Washington University IACUC.

2.3.2 Laser Capture Microdissection
One group (n=9) of mice was sacrificed by CO2 asphyxiation 4 hours after the first
loading bout to capture the regulation of genes involved in mechanotransduction shortly after
stimulation (Figure 2.1A). The second group (n=7, one was excluded due to a lesion on right
ankle) was subjected to five daily loading bouts and sacrificed 4 hours after the final bout to
represent the genetic regulation occurring during a state of active bone formation [80][81].
Loaded and contralateral control tibias were harvested within 3 min following sacrifice and
immediately embedded in Optimal Cutting Temperature compound (Tissue-Tek, Thermo Fisher
Scientific) with liquid nitrogen. Bones were kept at -80°C until later use.
For each bone (n=32), eight cryosections 10 µm thick were cut using Kawomoto’s LMD
film (Section-Lab Co. Ltd.) and the ends were glued onto a custom slide with the tissue facing
down over a window cut into the slide. The sections were kept on dry ice throughout the
experiment and LCM was performed on the same day as sectioning to preserve RNA integrity.
A Leica Laser Capture Microdissection microscope (LMD-6000, Leica) was used to
dissect two tissue regions, either the intracortical bone (Intra-CB) or outer mixed tissue (Mixed),
the latter of which included cortical bone, periosteum, and muscle (Figure 2.1B). The Mixed ROI
was intended to include the cell types that would contribute to whole-bone samples used for bulk
RNA analysis (except marrow), and provided a contrast to the more homogeneous Intra-CB.
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Because the Mixed ROI includes periosteal osteoblasts, gene expression from these cells was
expected to drive many of the changes occurring due to loading in these samples. On the 5x
objective, the region of interest (ROI) began approximately 4 mm distal to the tibial plateau
(Figure 2.2). Laser cuts on the compressive side of the tibia were made on the 10x objective with
power set to 45-60, aperture set to 32-35 and frequency set to 1404; the kerf of the laser cut was
~10 mm. The total length of tissue regions dissected was 2-3 mm with a width of approximately
100 µm. The cut-out pieces from each dissected region dropped into a 0.6 ml tube, positioned
under the tissue, filled with extraction buffer (Arcturus PicoPure RNA Isolation Kit, Applied
Biosystems, Thermo Fisher Scientific). After each section was dissected, the tube was placed on
dry ice. Four sections were dissected for each region type. Each section took less than 10 min to
dissect and dry ice was used to keep the section cool during the process. Tubes were kept at 80°C until further processing. Residual surface bone tissue was seen on the Intra-CB sections
after dissection, which provided a visual check that surface cells were not included in these
samples (Figure 2.1D). Additional sections were taken from a sample to confirm residual
osteoblasts on the slide following dissection of the Intra-CB ROI (Figure 2.2F,G). Sections were
cut as described, dissected, and Kawomoto’s film was mounted onto glass slides with chitosan
adhesive. DAPI staining was performed to localize cells.
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Figure 2.1: Experimental design and workflow. (A) Flow chart showing experimental parameters for mechanical
loading of mice; bones were harvested and embedded 4 h after last loading bout, on either day 1 or day 5. (B)
Diagram illustrating Intra-CB (blue outline) and Mixed regions (blue outline) collected for RNA extraction.
Yellow=Muscle, Blue=Osteoblasts and Progenitor Cells, Grey=Osteocytes. (C) Workflow from sample collection to
microarray data processing and analysis.
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Figure 2.2: Examples of ROIs for dissected Intra-CB and Mixed tissues. (A) Tissue samples were dissected
from 2-3mm ROIs of the compressive cortex (*) approximately 4 mm distal to the tibial plateau. (B) Example of a
portion of the ROI before dissection with the Intra-CB outlined in white and Mixed region outlined in blue. These
were cut tissues from adjacent, non-overlapping regions along the bone length. Mixed regions included tissues
adjacent to the periosteal bone surface (muscle and periosteum) in addition to cortical bone. (C) Dissected Intra-CB
pieces can be seen inside of the cap directly underneath the tissue section containing extraction buffer. (D) Example
of dissected Intra-CB. A dark outline of remaining cortical bone is visible. Only the upper cortex (*compressive)
was used for analysis. (E) Example of dissected Mixed ROI showing the dissected region was extended into the
muscle and less Intra-CB was removed. (F) Dissected Intra-CB ROI shows residual cells at the bone surface,
muscle, and marrow. (G) Dissected Mixed ROI lacks any bone surface cells but muscle, marrow and some Intra-CB
remains. Dissected sections were stained with DAPI.
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Each tube was thawed, vortexed and heated to 42°C for 30 min. Dissected tissue from
sections from the same limb and region type were pooled for extraction, resulting in 64
biological samples (from 32 bones; 16 pairs of loaded and control tibias) each eluted in 11 µl of
buffer (Arcturus PicoPure RNA Isolation Kit; Applied Biosystems) (Figure 2.1C). Agilent RNA
6000 Pico (Bioanalyzer 2100, Agilent Technologies) was used as an initial screening to measure
RNA concentration (mean = 126 pg/µl, range: 11 to 644 pg/µl) and RIN (mean = 3, range: 1 to
9). By visual inspection of the bioanalyzer traces, pairs were removed that contained a highly
degraded or contaminated sample (Figure 2.3). Forty-four (44) samples with adequate
Bioanalyzer traces remained for subsequent processing steps (n=6 Intra-CB pairs, n=5 Mixed
pairs for each timepoint).
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Figure 2.3: Samples with noticeable degradation, visualized on bioanalyzer traces, were excluded from
analysis. (A) Adequate RNA (99 pg/µl) allowed detection of 18S and 28S peaks (RIN=8.7). (B) Other samples
varied in amount of RNA present as shown by lower peaks (71 pg/µl, RIN=6.5), but were included in following
steps because no degradation was evident. (C) Several samples had no noticeable peaks but were included in
subsequent processing steps because no degradation was apparent and concentration was near or below the limit for
detection (21 pg/µl, RIN=1). (D-F) Samples were excluded from processing steps for noticeable degradation. (D)
RIN=2.5, Concentration=384 pg/µl, (E) RIN=N/A, Concentration=604 pg/µl, (F) RIN=N/A, Concentration=6 pg/µl.

2.3.3 Microarray
The Genome Technology Access Center (GTAC, Washington University in St. Louis)
performed RNA amplification and preparation of RNA, hybridization to microarray chips, and
normalization of raw intensity data. GeneChip Whole Transcriptome Pico Kit (Affymetrix,
Applied Biosystems, Thermo Fisher Scientific) was used to prepare samples for hybridization.
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This assay begins with reverse transcription along the length of RNA, making it well suited for
samples with low RIN. Total RNA was converted to complementary RNA (cRNA) and
amplified for 12 cycles of PCR before amplification with T7 in vitro transcription (IVT)
technology. Spectrophotometer (Nanophotometer NP60, Implen) analysis was used to determine
if samples needed speed vacuuming (<20 µg, n=5) before continuing. Five samples in total were
speed vacuumed. Subsequently, cRNA was converted to ss-cDNA and spectrophotometer
analysis confirmed adequate concentration for fragmentation and biotinylation (5.5 µg). Agilent
RNA 6000 Nano (Bioanalyzer 2100, Agilent Technologies) traces were visually inspected after
ss-cDNA generation for additional quality control before hybridization.
Hybridization of 2.5 µg of ss-cDNA to Clariom S Pico array (Applied Biosystems, Thermo
Fisher Scientific) occurred overnight at 45°C for 18 hours in a GeneChip Hybridization Oven
640 (Affymetrix, Thermo Fisher Scientific). The Hybridization, Wash, and Stain Kit for
cartridge arrays (Thermo Fisher Scientific) was used to wash and stain the arrays in an
Affymetrix Fluidics Station 450 (Thermo Fisher Scientific). Arrays were scanned using an
Affymetrix GeneChip 7G 3000 Scanner (Affymetrix, Thermo Fisher Scientific). The Clariom S
Pico Assay allowed detection of over 20,000 annotated genes. Probe intensities (.cel files) were
normalized and background corrected using Robust Mult-Array Average (RMA) with Partek
Genomics Suite (v6.6, Partek, Inc.). Measures of microarray chip quality, including Area Under
Curve (AUC) of the Receiver Operator Curve (ROC) and absolute deviation of the residuals
from the median (mad residual mean) showed limited RNA degradation and no outliers were
identified (Figure 2.4).
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Figure 2.4: No outliers or degraded RNA were found using quality control measures. (A) Positive and negative
probes separate well with AUC of the ROC (purple) greater than 0.8 for all samples. The variation between
microarray chips is adequate, demonstrated by the mean of the absolute deviation of the residuals from the median
(mad residual mean) for all probe sets (red) and positive control probes (blue). (B) Box plots for the intensity of
probes for each microarray chip further demonstrates little variation between chips. (C) Background intensity (red)
and Perfect Match probe intensities (blue) for each microarray separate well.
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2.3.4 Differential Expression Analysis
The normalized intensities (.chp files) were analyzed for differential expression in
Transcriptome Analysis Console (TAC) software (Applied Biosystems, Thermo Fisher
Scientific). First, Intra-CB gene intensities were compared to Mixed samples. Principal
component analysis (PCA) of all the genes and hierarchical clustering analysis of the genes with
Log2 intensities greater than 9 (>4,000 genes) were used to confirm primary differences due to
region type (Intra-CB vs. Mixed). One sample was not clearly labeled (Day 5 Intra-CB/Mixed)
and was removed from analysis, yielding n=4-6 pairs per group/time (Day 1 Intra-CB, n=6; Day
5 Intra-CB, n=5; Day 1 Mixed, n=5; Day 5 Mixed, n=4). Differentially expressed genes (DEGs)
due to loading were identified in the Intra-CB and Mixed samples separately at each timepoint.
Because differences due to loading were not robust, a relatively permissive DEG criteria was
used: fold change (FC, loaded/non-loaded) of FC ≤ 0.71 or ≥ 1.4, p-value < 0.01, using repeated
measures for tibias from the same mouse. The eBayes method was used for multiple
comparisons and default settings were used for other parameters.
DEG lists and intensity values were exported from TAC and genes shared by region and
timepoint were discovered. Lists for each group were compared using the VennDiagram package
in R. Loading DEGs were also compared to lists of loading DEGs identified from bulk RNAseq
as reported in Chermside-Scabbo et al. [80]. DEGs from Chermside-Scabbo et al. represented
bulk tissue gene expression, which included the tibia with muscle removed and marrow spun out;
similar mice (female, C57Bl/6, 5 mo), loading parameters (-8 N peak force), and timepoints (4 hr
after 1 bout and 5 bouts) were used in their study design [80].
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2.3.5 Gene Ontology and Cell Type Analysis
Differential regulation of biological processes were determined by importing DEG lists
into the Gene Ontology (GO) Enrichment Analysis tool (The Gene Ontology Consortium) [95]–
[97] and analyzed using Fisher’s Exact test and False Discovery Rate < 0.15. The genes driving
each of the top 10 processes (by fold enrichment) were visualized in heatmaps (Prism 8.4.2,
GraphPad Software) with their respective loading-induced FC.
Intra-CB regions may include blood vessels that transport immune cells and depend on
osteoclastic bone resorption for growth and development [12]. Furthermore, changes in these
structures due to disease or drug administration can occur rapidly [12]. To investigate any
changes occurring in vasculature due to loading, gene lists for endothelial cells compiled by
Coates et al. for RNAseq cell phenotyping [98] were incorporated into our analysis.
Additionally, osteocytes have been known to express many genes to remodel their local
environment and regulate osteoblasts and osteoclasts [23], [87], [99], [100]. To determine if
osteocyte expression of osteoblast and osteoclast factors are different by timepoint, gene lists
associated with osteoblasts and osteoclasts from Coates et al. were also imported into TAC and
visualized in heatmaps as previously described. Neuron associated gene lists were also collected
from Youlten et al [101] and Paic et al. [102] for analysis.

2.3.6 In Situ Hybridization and Immunohistochemistry
Loaded and contralateral control tibias were partially trimmed of muscle and fixed in
10% neutral buffered formalin overnight. Bones were washed in PBS and decalcified for 14 days
in 14% EDTA (pH=7.4) at 4°C. After full decalcification, bones were paraffin embedded and
kept in humidity-controlled containers until sectioning.
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Paraffin sections for staining were cut 5 µm thick on Superfrost Plus Microscope Slides
(Fisher Scientific) and baked overnight at 60°C. Sections were kept in containers with desiccant
until staining. RNA in situ hybridization using RNAscope 2.5HD Duplex Assay (Advanced Cell
Diagnostics, Inc.) was performed following manufacturer’s directions with a few modifications.
Slides were baked overnight at 37°C before the procedure. Before deparaffinization, slides were
baked for 30 min at 60°C. Additional baking steps at 60°C for 10 min were added before and
after applying the hydrophobic barrier around the tissue and after target retrieval for 30 min at
60°C. In addition to the baking steps, pepsin treatment was used for target retrieval for 45 min at
40°C in place of the manufacturer’s suggested reagents. Amplification steps 6 and 10 were also
increased to 30 min. Ngf (446331) and Wnt1 (401091-C2) probes were selected with channel 1
(C1: HRP-based Green) and channel 2 (C2: AP-based Fast Red), respectively. Positive control
probes targeted Ppib (C1) and Polr2a (C2). Negative control probes targeted a bacterial gene
(dapB). Both control probe reagents were provided in the Duplex detection kit. Images were
acquired at 40x on a Nanozoomer 2.0HT microscope (Hamamatsu) for quantification and on a
confocal microscope with a DFC7000 T camera (Leica Microsystems) for closer inspection at
63x. Following initial imaging, the coverslips on a few sections were removed and
counterstained with 50% hematoxylin (Hematoxylin Solution, Gill No. 1, Sigma Aldrich) diluted
in 0.02% ammonium hydroxide (Sigma Aldrich) after initial imaging, but some loss of staining
occurred. NDP.view 2.3 software (Hamamatsu) was used to export 1-mm regions of interest
(ROI). The ROI location was approximately 5 mm distal to the tibial plateau (site of peak strain).
The precise position was adjusted on some samples to avoid regions with tissue sectioning
artifacts, but each tibial pair had matching ROI locations. The number of Ngf (blue) and Wnt1
(pink) positive punctate dots per ROI were counted, as well as the number of lacunae per ROI
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stained with multiple Ngf or Wnt1 mRNA molecules using BIOQUANT OSTEO software
(Bioquant Imaging Analysis Corp.). Samples were blinded.
For immunohistochemistry (IHC), sections were deparaffinized, followed by antigen
retrieval incubation with Unitrieve antigen retrieval solution (Innovex Biosciences) in a 60°C
water bath for 30 min. Endogenous peroxidases were blocked with 3% H2O2 (Sigma-Aldrich) at
room temperature for 10 min and sections were blocked using 20% goat serum (ab7481,
Abcam). 1:50 anti-MMP13 rabbit antibody (ab39012, Lot GR3365904-1, Abcam) or normal
rabbit IgG (2729S, Lot 8, Cell Signaling Technologies) was applied overnight at 4°C. Sections
were incubated in 1:100 goat anti-rabbit HRP secondary antibody (P0448, Lot 20042622, Dako)
for 30 min at room temperature. Peroxidase reaction was performed with ImmPACT DAB
Substrate Peroxidase kit (SK-4105, Lot ZF0830, Vector Laboratories, Maravai LifeSciences) for
6 min. Sections were counterstained with hematoxylin (Modified Mayer’s, Electron Microscopy
Sciences). Images were acquired at 20x on a Nanozoomer 2.0HT microscope. ROIs were
obtained as described for RNAscope quantification. Samples were blinded and cells (total and
MMP13-positive) within Intra-CB were counted using BIOQUANT OSTEO software.

2.3.7 Statistics
Statistics for in situ and IHC quantification were conducted using a two-way ANOVA with
repeated measures and factors including loading and timepoint. Sidak’s multiple comparisons
test was used for post-hoc analysis (Prism 8.4.2, GraphPad Software). Significance was defined
as p<0.05, with marginal differences noted at p<0.10.
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2.4 Results
2.4.1 Regions Dissected From Intra-CB are Enriched for Osteocyte-specific
Genes
PCA showed that the majority (58%) of variation in gene expression intensities across all
samples can be explained by the first principal component (PC1), with samples clearly separated
by region type along this axis (Figure 2.5A). In contrast, PC2 explained only 5.4% of variation,
with non-loaded and loaded samples of the Mixed type marginally separated along this axis.
Hierarchical mapping also showed clustering of samples primarily by region type; secondary
clustering by loading or timepoint was not apparent (Figure 2.5B). Together, PCA and clustering
analysis indicate that Intra-CB and Mixed samples have different expression profiles, consistent
with Intra-CB samples lacking some of the cells that are contained in Mixed samples. Additional
PCA, performed for each tissue type and timepoint separately, demonstrated a strong separation
between non-loaded and loaded samples along PC1 (Figure 2.6). The greatest amount of sample
variation explained by PC1 was seen in the Mixed region type on day 5 (PC1, 55%) compared to
other groups (PC1, 30-35%). Greater variance due to loading in the Mixed region on day 5 is
consistent with periosteal osteoblasts being more transcriptionally active at this timepoint,
consistent with active periosteal bone formation. By contrast, periosteal osteoblasts are not fully
active on day 1 [80], nor are the changes associated with active osteoblasts captured within IntraCB samples.
Genes known to have higher expression in osteocytes compared to other musculoskeletal
cells (Sost, Dmp1, Phex, Mepe) [48] were highly expressed in Intra-CB, each above or near the
90th percentile in terms of signal intensity. Moreover, each showed over 2-fold greater expression
in Intra-CB compared to Mixed samples (FC=3.4, 2.2, 4.6, 3.0, respectively, p<0.001, Figure
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2.5C). Dkk1 was also expressed higher in Intra-CB tissue, although Fgf23 and Pdpn were not
different. Sca-1 and Prrx1, known to be expressed by bone lining cells and osteochondral
progenitors in the periosteum [7], [49], [103], [104], were expressed 1.7 and 2.2 fold higher,
respectively, in Mixed regions compared to Intra-CB (p<0.001, Figure 2.5D). Alpl which is
abundantly expressed by early osteoblasts to provide phosphate for mineralization [105], also
showed 2.0-fold higher expression intensity in mixed regions. However, two other genes
expressed at high levels during active bone formation, Col1a1 and Bglap, were expressed at
similar levels between region type (p=0.58, p=0.096, Figure 2.5D). Several other genes typically
associated with osteoblasts were either expressed more in Mixed tissue (Col5a1, Tmem119), not
different by tissue type (Col1a2, Fkbp10, Gja1, Ibsp, Kdelr3, Maged1, Pard6g, Rcn3, Sparc), or
expressed higher in Intra-CB (Runx2, Sp7, Spp1). We found no enrichment for osteoclasts or
endothelial cells in either tissue type. Three genes expressed highly in skeletal muscle (Myh2,
Ankrd23, Myh1) [106], [107] were expressed at over 13-fold higher intensity in Mixed regions
compared to Intra-CB (FC=30.7, 15.4, 13.3, respectively, p<0.001, Figure 2.5E). The enhanced
gene expression intensity of osteocyte specific genes, combined with decreased expression of
early osteoblast, osteochondral progenitor, and muscle genes in Intra-CB supports an enrichment
for osteocytes within the cortical bone region.
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Figure 2.5: LCM allowed dissection of distinct populations of cells from mouse tibias. (A) PCA of gene
expression from regions of Intra-CB (n=22) and mixed tissue (n=18) showed separation of region-type along PC1.
Loaded and non-loaded samples were not clearly separated. (B) Heat map of Log2 gene expression intensities of
genes with average Intra-CB Log2 intensities greater than 9 (4,105 genes). This representation of highest expressing
genes clustered primarily by region type. (C-E) Select genes demonstrated (C) higher expression of osteocytespecific genes in Intra-CB, (D) higher expression of Alpl, Sca-1 and Prrx1 and (E) muscle related genes in mixed
regions. *FDR p-value<0.05

33

Figure 2.6: PCA for each region type and timepoint shows greatest variance due to loading in the Mixed Day
5 group. PCA was conducted within (A-B) Intra-CB and (C-D) Mixed regions separately.

2.4.2 Loading Induces Differential Expression of >100 Genes in Intracortical
and Mixed Regions at Days 1 and 5
A robust increase in the number of loading DEGs occurred from day 1 (159) to day 5
(550) in the Mixed region, consistent with increased periosteal osteoblast activity during active
bone formation at this timepoint (Figure 2.7A). In the Intra-CB region, the number of loading
DEGs was comparable at days 1 and 5, but of the 153 Day 1 DEGs, only 10 remain differentially
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regulated on day 5, and they are all upregulated due to loading (Figure 2.7B, C). Ngf, an
important regulator of loading-induced bone formation known to be expressed by osteoblasts
[85], had the highest FC on day 1 (13.5) and day 5 (11.1). Kcne3, a gene responsive to Vegfa
(also upregulated on both days) and expressed by endothelial tip cells was upregulated over 5fold on day 1 and over 3-fold on day 5 [108]. The only genes to increase their magnitude by at
least 1.0 FC from day 1 to day 5 were Inhba (2.5 to 3.5) and Wnt1 (1.5 to 5.1). Inhba can form
subunits for activin or inhibin which both have important roles in modulating TGF-ꞵ and BMP
signaling, and have been shown to affect differentiation of osteoblasts and osteoclasts [109].
Wnt1 has been noted previously as a loading-induced gene in bone [9], [36], [80], [81].
Many genes upregulated on day 1 did not remain up on day 5. Four of the most highly
upregulated genes in Intra-CB on day 1 (Enkur, Egr1, Tnfrsf12a, Timp1) were not differentially
expressed on day 5 (Table 2.1). Enkur encodes a protein that binds to calmodulin and may be
important for signal transduction via calcium channels [110], [111], but has not been identified in
bone. Calcium channel signaling is activated early in the mechanotransduction process by
osteocytes [35]. Early growth response 1 (Egr1), has been shown to play a role in many factors
relating to proliferation and differentiation as well as regulation of Postn, Bglap, and Ctsk [112],
[113]. Tnfrsf12a is not well known in the context of bone formation, but this TNF ligand has
been reported to be upregulated by loading [9], [80] and to bind to mesenchymal progenitor cells
and activate NF-κB [114]. Tissue inhibitor of metallopeptidase inhibitor 1 (Timp1) inhibits
matrix metalloproteinases and extracellular remodeling and has been shown to enhance the
anabolic response to parathyroid hormone [115]. More recently, TIMP1 was shown to suppress
osteoblast and osteoclast differentiation, mediated by Wnt signaling [116], [117].
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Table 2.1: Intra-CB top 20 upregulated DEGs by fold change
Day 1
Gene ID

Ngf
Kcne3
Enkur
Egr1
Tnfrsf12a
Egr2
Timp1
Lmcd1
Dusp6
Vegfa
Zeb1
Inhba
Baalc
Pdgfa
Hspb7
Dot1l
Stc1
Gem
Mpdz
Crem

NonLoaded
Intensity
(Log2)

Linear FC
(Loaded/NonLoaded)

P-val

Gene ID

7.1
7.2
5.2
9.0
9.1

13.5

1.62E-05

Ngf

5.1
3.4
3.4
3.3

0.0007
0.0052
0.0005
0.0003

Anxa8
Wnt1
Pappa
Adm

8.5
8.4
8.8
9.8
10.5
7.8
7.4
6.1
8.9
8.0
8.5
7.0
6.5
5.5
7.2

3.2

0.0003

Kcne3

3.1
2.8
2.5
2.5
2.5
2.5
2.4
2.4
2.4
2.4
2.4
2.4
2.4
2.2

0.0007
0.0004
0.0014
0.0057
0.0036
0.0038
0.0001
0.0041
0.0053
0.0029
0.0068
0.0092
0.004
0.0082

Lox
Inhba
Apln
Ptgs2
Cgref1
Bmp2
Pik3r3
Col5a2
Prex2
Ildr2
Asic3
Tmie
Rasl11a
Tnfrsf11b

Day 5
NonLinear FC
Loaded
(Loaded/NonIntensity
Loaded)
(Log2)

7.4
8.4
5.3
8.1
9.1

11.1

8.1
7.1
7.4
7.7
5.3
8.0
6.8
7.0
7.4
5.6
6.7
9.1
8.4
5.4
9.7

3.8

7.1
5.1
5.1
4.5

3.8
3.5
3.1
2.9
2.8
2.7
2.7
2.6
2.6
2.5
2.5
2.5
2.3
2.3

P-val
1.50E05
0.0009
0.0002
0.0001
0.0068
1.79E05
0.0037
0.0001
0.0016
0.0014
0.0083
0.0092
0.0004
0.0029
0.0012
0.006
0.0062
0.0049
0.0085
0.0052

Consistent with an increase in Timp1 on day 1, by day 5 a decrease in Mmp13 expression
occurred (0.3-fold, Table 2.2). Matrix metalloproteinase (MMP)-13 has been identified in
osteocyte perilacunar remodeling [118]. Of the genes upregulated by loading on day 5 that were
not induced on day 1, Annexin A8 (Anxa8) was the most upregulated (FC=7.1). AnxA8 plays
roles in osteoclast differentiation [119], endosome trafficking [120], and Wnt signaling in
epithelial cells [121]. Pregnancy-Associated Plasma Protein A, Pappalysin 1 (Pappa) was also
upregulated over 5-fold on day 5. This gene is known for its regulation of insulin-like growth
factor (IGF) bioavailability [122]. IGF signaling has been shown to increase following loading,
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mediated by Igf-1 [123]–[126]. Adrenomedullin (Adm) was increased 4.5-fold on day 5 due to
loading and has also been shown to play a role in bone formation as an osteoblast expressed
protein [127]. Finally, Lox, Apln, and Ptgs2 were also top DEGs upregulated due to loading on
day 5. Lox encodes for the protein lysyl oxidase which is important for collagen fiber crosslinking and affects differentiation of osteoblasts and osteoclasts [128]. Interestingly, Apln
knockout mice have increased cancellous bone volume and cortical bone perimeter, which was
attributed to an increase in osteoblast proliferation mediated by adipose tissue [129].
Cyclooxygenase-2 (Ptgs2 or Cox-2) is well-known for its important role in early
mechanotransduction by osteocytes in the context of loading [40], [41], [74]. These genes might
play a role in maintaining the response to loading since they were upregulated only on day 5, or
their expression could be secondary to earlier changes in transcription.
Table 2.2: Intra-CB top 20 downregulated DEGs by fold change
Day 1

Gene ID

Prmt2;
Mir678
Sep4
Cd55
Gpn1
Trim30d
Aqp9
Mapk1
Xpo1
Tg
Phf20
Nxt2
Drg2
Cbr2
Rnf213

NonLoaded
Intensity
(Log2)

7.7
8.5
7.6
7.3
7.8
9.1
7.8
8.8
11.1
6.3
8.3
8.6
8.4
9.4

Day 5

Linear FC
(Loaded/N
onLoaded)

P-val

Gene ID

0.3

0.0022

Atp6v0d2

0.3
0.3
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4

2.65E-05
0.0054
0.0024
0.0054
0.0083
0.007
0.0029
0.0094
0.002
0.0036
0.0067
0.0075

Pax5
Hspa4l
Jchain
Lrguk
Stk26
Acp5
Mmp13
Pqlc3
Panx1
Pde3b
Tbc1d13
Tespa1

0.4

0.0003

Lcp2
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NonLoaded
Intensity
(Log2)

8.0
9.5
6.3
9.9
6.2
9.6
11.6
10.5
9.3
7.8
7.9
7.4
7.7
7.9

Linear
FC
(Loaded/
NonLoaded)
0.2
0.2
0.2
0.2
0.3
0.3
0.3
0.3
0.3
0.4
0.4
0.4
0.4
0.4

P-val

5.81E05
0.0064
0.0019
0.0041
0.0075
0.0094
0.0005
0.0003
0.0054
0.0013
0.0009
0.0028
0.0006
5.19E05

Ccl8
Cdc6
Anpep
Clasp2
Igtp
Lynx1

6.8
9.0
8.8
8.1
7.6
8.5

0.5
0.5
0.5
0.5
0.5
0.5

0.0026
0.0036
0.0091
0.0062
0.0013
0.0016

Nckap1l
A530088E08Rik
Clec12a
Lpar5
Dcstamp
Hyls1

9.0
7.0
10.5
6.5
7.8
8.6

0.4
0.4
0.4
0.4
0.4
0.4

0.0062
0.0018
0.0033
0.0021
0.0055
0.0063

Overall, few DEGs were shared between region types on day 1 (7 of 159) or day 5 (30 of
550) (Figure 2.7B). Of these genes on day 1, the FC was of greater magnitude in Intra-CB
compared to Mixed regions, with Ngf and Timp1 having the highest upregulation and Prmt2
having the greatest downregulation (Figure 2.7D). Protein Arginine Methyltransferase 2 (Prmt2)
is a well-known inhibitor of NF-κB-dependent transcription which is critical for
osteoclastogenesis [130], [131]. Of the shared genes by region type on day 5 (Figure 2.7E),
several genes had greater FC induced by loading in Mixed regions compared to Intra-CB
(Cgref1, Col5a2, Cdo1, Mpv17l, Bglap3, Adamts9). These genes are involved in ion binding
(Cgref1, Cdo1, Bglap3) [132]–[134], cell signaling (Mpv17l) [135], and extracellular matrix
remodeling (Col5a2, Adamts9) [136], [137]. Ngf and Lox were also upregulated in both regions,
but with greater FC in Intra-CB. Ngf was the only gene differentially regulated in both regions on
both days, although FC was substantially lower when other tissues were present (Day 1, 13.5 vs.
2.2).
To better understand the effect of isolating specific tissue regions on gene expression
analysis, we compared Intra-CB and Mixed DEGs to Bulk tissue DEGs from Chermside-Scabbo
et al. [80] (Figure 2.8). This comparison revealed more similarity between Bulk tissue and IntraCB on day 1 (37% overlap) compared to day 5 (3% overlap) (Figure 2.8). The genes shared by
Bulk tissue and Intra-CB on day 1 included genes also reported by others at early timepoints,
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including Ngf, Tnfrsf12a, Pdgfa and Wnt1 [9] (Figure 2.8). Most DEGs in Bulk tissue were not
detected in Mixed regions, but 37 genes did overlap between day 5 Mixed and Bulk tissue
(Figure 2.8). These genes included Cgref1, Cdo1, and Bglap3 (Figure 2.8), which were also more
enhanced (by FC) in Mixed regions compared to Intra-CB on day 5.
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Figure 2.7: More than 150 genes are differentially regulated by loading in Intra-CB on each day, with only 10
genes in common at both timepoints. (A) The number of DEGs is similar on both days in Intra-CB samples but an
increase in number of DEGs occurs on day 5 in mixed regions. (B) Most genes are not shared between regions or
timepoints. (C-D) Differentially regulated genes (C) in Intra-CB and (D) Mixed regions on both days (all 10, 9
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shown) (E) in both regions on day1 (all 7 shown) and (F) in both regions on day 5 (top 10 shown). Values are basal
gene intensity (Log2) and absolute fold change due to loading (loaded/non-loaded).

Figure 2.8: Intra-CB regulation is more similar to previous findings in Bulk bone tissue samples (from
Chermside-Scabbo et al. [15] on day 1 compared to day 5. (A) 37% of the 19 DEGs on day 1 in Bulk tissue are
also DEGs on day 1 in Intra-CB, but only 3% of DEGs on day 5 in Bulk tissue are also differentially regulated in
Intra-CB. In contrast, (B) only 1 DEG (5%) from Bulk tissue is also identified on day 1 in Mixed regions and 10%
are in common on day 5. (C) FC of genes expressed in Intra-CB that are also upregulated in Bulk tissue on day 1.
(D) Top 10 DEGs by FC that are upregulated in Mixed regions and Bulk tissue on day 5.

2.4.3 Ngf and Wnt1 are Expressed by Osteocytes
We selected Wnt1 and Ngf for spatial analysis using RNAScope, based on their significant
upregulation on days 1 and 5 in Intra-CB. RNA molecules represented by punctate dots, were
quantified throughout the 1-mm ROI and normalized by area (Figure 2.9A). Wnt1 and Ngf
mRNA molecules can be readily seen in the loaded and non-loaded Intra-CB samples (Figure
2.9B,C). Negative control probes targeting bacterial genes can be seen to a minimal degree,
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indicating limited non-specific staining for this assay (Figure 2.9D). Positive control probes
show more intense staining in osteocytes (although not abundant), marrow, and periosteum
(Figure 2.9E). Loading did not significantly increase Ngf mRNA molecules within Intra-CB at
either timepoint (Figure 2.9F), but the number of lacunae within the bone containing multiple
Ngf mRNA molecules showed a marginal increase (p=0.09, Figure 2.10A). In support of the
microarray data, Wnt1 increased over 2-fold with loading on day 1, but unlike the microarray
data, no change was detected on day 5 (Figure 2.9G). Similarly, Wnt1+ lacunae increased
significantly with loading on day 1 but not day 5 (Figure 2.10B). We also identified Wnt1 and
Ngf mRNA within the periosteum (Figure 2.11), but these punctae were not quantified due to
limited regions with intact and identifiable periosteum.
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Figure 2.9: Loading increases Wnt1 expression in Intra-CB. (A) A region approximately 1-mm in length was
analyzed for Wnt1 (red) or Ngf (blue) punctate dots representing RNA transcripts targeted by their respective probes
(arrows). Representative images show the (B) loaded tibia had more Ngf and Wnt1 expression (in this sample)
compared to (C) non-loaded tibias and (D) negative control probes detected minimal RNA transcripts within IntraCB. (E) Positive control probes show staining in Intra-CB, and more abundantly in marrow, and periosteum.

43

Punctate dots were quantified, showing (F) no significant change in Ngf at either timepoint and (G) a substantial
increase in Wnt1 expression on day 1. Ma=Marrow, P.s.=Periosteal Surface.

Figure 2.10: Loading increases number of Wnt1-expressing osteocytes. (A) Lacunae with Ngf+ punctae
increased slightly on day 1, but not significantly (p=0.09). (B) Number of Wnt1-expressing lacunae significantly
increased with loading on day 1. (C) Counterstained slides showed Wnt1 accumulating around osteocyte nuclei and
in cortical bone matrix. Ngf mRNA molecules were no longer present following additional washes.
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Figure 2.11: Ngf and Wnt1 mRNA was detected in the periosteum. Arrows point to punctate dots confirming
Ngf (blue) and Wnt1 (pink) expression in the periosteum. Arrow heads demarcate the edge of the cortical bone.

2.4.4 MMP13 is Downregulated in Osteocytes from Loaded Tibias
MMP13 IHC was performed to confirm downregulation shown by microarray in Intra-CB
on day 5. MMP13+ osteocytes were quantified within a region close to maximal strain (Figure
2.12A-B). Qualitatively, more MMP13+ osteocytes can be seen in the non-loaded compared to
loaded tibias (Figure 2.12C-E). Rabbit IgG controls indicated negligible non-specific staining
(Figure 2.12F). Consistent with microarray data, percentage of MMP13+ osteocytes showed a
marginal decrease in loaded tibias vs. non-loaded tibias on day 5 (p=0.08, Figure 2.12G).
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Figure 2.12: MMP13 staining decreases with loading. (A) The region of Interest (ROI) was centered near the
region of maximal strain, 5 mm distal to the tibial plateau (T.P.) with adjustments made for tissue artifacts. (B) An
approximately 1-mm in length ROI was selected for quantification of MMP13+ osteocytes. (C) MMP13 staining is
apparent in non-loaded tibias in the periosteum and Intra-CB. (D-E) MMP13 staining in loaded tibias on day 1 (D)
and day 5 (E). (F) Rabbit IgG shows negligible non-specific staining in a non-loaded tibia. (G) Quantification of
osteocyte positive cells show a decrease with loading on day 5. N=5/timepoint. Mu=Muscle, Ma=Marrow.
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2.4.5 Vascular Development, Neuronal, and Immune Cell Biological
Processes are Enriched in Intra-CB Bone by Loading
GO biological processes were investigated using DEG lists for Intra-CB on days 1 and 5.
Twenty biological processes were enriched on day 1 (Figure 2.13A), with 41 DEGs driving the
top 10 processes by Fold Enrichment (FE) (Figure 2.13B). Positive regulation of fibroblast
proliferation had the greatest FE (11.23) on day 1 and was driven by Pdgfa (FC=2.4), Sphk1
(FC=1.7), Wnt1 (FC=1.5), Tgfb1 (FC=1.4), and Cdc6 (FC=0.5). Myeloid leukocyte
differentiation was also highly enriched (FE=7.7) with Vegfa (FC=2.5), Nfatc1 (FC=2.0), Oscar
(FC=1.9), Junb (FC=1.8), Kdm1a (FC=1.7), and Tgfb1 (FC=1.4) contributing to its regulation.
Three terms within the top 10 were vascular related (vasculature development, tube
morphogenesis, circulatory system development) with FE ≥ 3. The genes with the highest FC
contributing to these processes included Egr1 (FC=3.4), Tnfrsf12a (FC=3.3), Vegfa and Zeb 1
(FC=2.5), and Pdgfa and Hspb7 (FC=2.4) being the most upregulated, while Mapk1 and Rnf213
(FC=0.4) were the most downregulated DEGs. Overall, Ngf, Kcne3, Egr1, Tnfrsf12a, and Timp1
contributed to at least one of the enriched biological processes on day 1 and had the greatest
loading-induced FC (FC > 3).
On day 5, almost 300 biological processes were enriched, but the top 10 biological
processes (by FE) (Figure 2.13C) were attributed to only 10 DEGs (Figure 2.13D). The genes
driving the two most enriched processes (positive regulation of hippocampal neuron apoptotic
process and positive regulation of microglial cell mediated cytotoxicity) were Tyrobp and Itgam
(FC=0.6). Another neuron related process, Ganglioside catabolic process, was also in the top 10
by FE, attributed to Hexb (FC=0.6) and Gm2a (FC=0.5). Four immune related processes were
also highly enriched (FE>45), including neutrophil differentiation and immune responseinhibiting cell surface receptor signaling pathway. These immune processes are driven by
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Dhrs7b (FC=1.6), Lef1 and H2-M3 (FC=0.7), and Lbr and Lyn (FC=0.6). Consistent with
enrichment of vascular processes on Day 1, processes for platelet activating factor metabolic
process, primitive hemopoiesis, and leukocyte adhesion to vascular endothelial cell were also
within the top 20 enriched processes on day 5. These processes were driven by Lox (FC=3.8),
Vegfa (FC=1.7), Pla2g7, Lpcat2 (FC=0.5), and Ptpn1 and Stk4 (FC=0.4). Dcstamp (FC=0.4) was
one of the most downregulated DEGs driving day 5 processes and contributed to the positive
regulation of macrophage fusion. In summary, immune and vasculature regulation occurred on
both days while neuron associated processes were enriched on day 5 only.
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Figure 2.13: Vascular (V), neuron (N), and immune (I) regulation are biological processes differentially
regulated by loading in Intra-CB. (A) Top 10 (by FC) enriched biological processes on Day 1 are driven by (B) 41
DEGs, while on Day 5 (C) the top 10 enriched biological processes are driven by (D) 10 DEGs.

2.4.6 Osteoclast, Osteoblast, and Endothelial Cell-associated Genes Were
Differentially Expressed Due to Loading in Intra-CB
Osteoclast, osteoblast, endothelial, immune, and neuronal cell-associated genes were
investigated in the Intra-CB specific data set. A priori gene lists for each cell type, except
neuronal associated genes (see below), were taken from Coates et. al. [98]. The osteoclast
associated gene list revealed upregulation of Oscar (FC=1.9) on day 1, and downregulation of
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Dcstamp, Ctsk, Mmp9, and Tyrobp on day 5 (FC= 0.4, 0.5, 0.6, 0.6 respectively), indicating a
downregulation of osteoclast differentiation factors on day 5 (Figure 2.14A). The osteoblast
associated gene list returned 6 genes (out of 16) that were upregulated on day 5 in Intra-CB
(Figure 2.14B), including Bglap, Col1a1 (FC=2.1), Col5a1 (FC=2.0), Alpl (FC=1.7), Sp7
(FC=1.6). These results indicate an upregulation of genes classically associated with osteoblast
differentiation and bone matrix synthesis on day 5, despite the lack of bone forming surfaces in
the Intra-CB region. The endothelial cell associated gene list returned 4 genes (out of 12) on day
1 that were differentially regulated with loading (Figure 2.14C). Vegfa (Day 1 FC=2.5, Day 5
FC=1.7) was upregulated on both days while Cspg4 (FC=1.8) and Cdh5 (FC=2.0) were
upregulated only on day 5, and Acta2 (FC=0.5) was downregulated on day 5. These data reveal a
potential role for endothelial cells in the loading response. Of the immune cell lists, 8 and 4
genes associated with T cells and B cells, respectively, were downregulated with loading while
other lists encompassed genes mostly unregulated by loading (Figure 2.15). Finally, a list of
neuron related genes was compiled from studies by Paic et. al. [102], and Youlten et. al. [101],
but no genes were significantly regulated by loading (Figure 2.15A).
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Figure 2.14: Loading-induced changes in expression of osteoclast, osteoblast, and endothelial cell related
genes occur in Intra-CB. (A) Osteoclast genes are downregulated on day 5. (B) Osteoblast genes are upregulated
on day 5. (C) Endothelial genes were similarly regulated on both days. Gene Lists from Coates et al. [98] * indicates
1.4 ≤ FC ≤ 0.71 & p<0.05 at 1 timepoint, ** indicates 1.4 ≤ FC ≤ 0.71 & p<0.05 at both timepoints.
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Figure 2.15: Loading induced minimal changes in genes associated with neuron, chondrocyte, and immune
cells. (A) Genes associated with neuron development and branching, from [102] and [101]. (B-G) Genes associated
with immune cells, from Coates et al. [98]. * indicates 1.4 ≤ FC ≤ 0.71 & p<0.05 at a single timepoint.

2.5 Discussion
The transcriptional response of osteocytes to in vivo mechanical loading has been difficult
to ascertain due to their location within mineralized matrix. Using laser capture microdissection
we isolated intracortical bone, without periosteal and endosteal cells, at mid-diaphyseal sites
known to experience high mechanical strain with axial tibial loading. We used microarray
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analysis to evaluate the transcriptional response of this osteocyte-enriched sample to loading, and
contrasted this to the response of a mixed tissue sample containing bone as well as periosteum
and muscle tissue. We showed enrichment for osteocyte-specific genes in Intra-CB regions
compared to Mixed regions, which expressed higher levels of some early osteoblast and
osteoprogenitor genes. We identified expression of genes classically associated with other cell
types within Intra-CB regions. This pattern has been described by Nioi et al., where Col1a1 and
Bglap were expressed higher in osteocytes compared to lining cells and active osteoblasts [87].
With loading, there were hundreds of differentially expressed genes in both regions, although
these were mostly non-overlapping. Notably, the set of loading DEGs in Intra-CB samples had
little overlap with DEGs reported from bulk tissue samples on day 5, when bone formation is
active in this model [80]. Therefore, the analysis of gene expression within Intra-CB samples
reveals responses to loading that are not identical to responses detected in more heterogenous
tissue samples. Focusing on these Intra-CB DEGs, we find that some previously described
responses to loading, namely upregulation of Wnt1 and Ngf, occur in osteocytes. We also find
differential regulation of genes related to vasculature and bone remodeling.
Wnt1 is a key regulator of bone mass and skeletal integrity in humans and mice [138],
[139]. Wnt1 deletion in Dmp1-Cre mice decreased bone mass while overexpression increased
osteoblast number and activity [138]. However, it is unclear if these effects were mediated by
osteocytes or osteoblasts, since Dmp1-Cre is known to target both cell types. In support of a role
for Wnt1 in osteocytes, our Intra-CB microarray and in situ hybridization results show, for the
first time, that a single bout of loading increases Wnt1 expression localized to intracortical
bone/osteocytes. Furthermore, our microarray data shows a sustained loading response on day 5
(5.1-fold increase), although in situ hybridization did not detect any differences at this timepoint.
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Holguin et al. showed sustained Wnt signaling in osteocytes in TOPGAL reporter mice similarly
loaded for 1 and 5 days [81]. Others have shown downregulation of SOST in response to loading
[9], [81], shown to be critical for increased Wnt signaling and subsequent bone formation [83].
Interestingly, we did not find a significant downregulation in Sost due to loading at either
timepoint, although the data showed a marginal change in that direction (Day 1, FC= 0.8,
p=0.09; Day 5, FC=0.8, p=0.1). While our results reveal Wnt1 induction in osteocytes with
loading, whether this plays a functional role in loading-induced bone formation remains to be
shown.
A major finding in this work was the robust loading-induced increase in Ngf expression in
Intra-CB on day 1 (13-fold) and day 5 (11-fold). No previous studies have shown Ngf expression
within cortical bone. We also found enrichment for positive regulation of hippocampal neuron
apoptotic process, which was over 100-fold enriched on day 5 in Intra-CB. Chermside-Scabbo et
al. also showed increased Ngf expression in addition to enrichment of pathways for neuron
projection [80]. Others have also reported enhanced expression of neuronal phenotypes in
osteocyte-enriched gene expression data [101], [102], but genes from these lists were not loading
DEGs in our data. Interestingly, the potassium gated channel gene Kcnk13 was identified as
more highly expressed in osteocyte cells compared to osteoblasts by Paic et al. [102], and we
found a similar gene (Kcne3) to be a top DEG with loading on day 1.
Our results showing Ngf expression in Intra-CB contrasts with work by Tomlinson et al.
showing increased expression due to loading in osteoblasts, but not osteocytes, using NGF-EGFP
mice and IHC [85]. This lack of expression in osteocytes was later supported in a fracture model
[140]. The conflicting results with our work could partially be explained if gene expression is
driven mainly by a few high-expressing osteocytes, or due in part to the different assays used.
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Our RNA extracts included four 10 µm thick sections from each bone which could have captured
a few very responsive osteocytes. In situ hybridization using RNAScope was able to confirm
presence of Ngf within Intra-CB, but did not confirm the robust increase in expression found in
the microarray data, although a marginal increase in Ngf+ lacunae with loading was observed.
Additionally, the RNAscope results did not show the abundance of Ngf detected by microarray.
At baseline, Ngf was near the median of expression intensities, and after loading expression was
above the 90th percentile of expression intensities.
MMP13 plays a role in osteocyte perilacunar remodeling [118], and we showed that
loading induced a strong downregulation of MMP13 expression in osteocytes. We also showed a
decrease in several osteoclast associated genes within Intra-CB samples due to loading
(Dcstamp, Ctsk, Mmp9, Tyrobp). Furthermore, several immune cell differentiation processes
were detected in the GO biological process analysis on day 5, with the majority of genes
contributing to these processes being downregulated. Osteoclasts derive from the same
monocytic lineage as macrophages, and have been shown to regulate immune cell activity [19].
Collectively, our results provide evidence that loading suppresses the expression of factors
related to both lacunocanalicular remodeling and osteoclastogenesis, suggesting broad inhibition
of bone remodeling.
Interestingly, we found several indications of vasculature changes induced by loading in
Intra-CB. Vasculature development was enriched 4-fold as a biological process on day 1, driven
primarily by loading-induced increases in Egr1, Tnfrsf12a, Vegfa and Pdgfa. We further showed
increases of endothelial cell associated genes (Vegfa, Cspg4, Cdh5). These results may indicate
osteocyte regulation of vasculature, induced by loading. Tomlinson et al. demonstrated an
increase in vascularity 7 days following loading stimulus in the rat forelimb, although they
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showed that this increase in blood vessel number was only necessary for woven bone but not
lamellar bone formation [141]. Besides driving angiogenesis at sites of new bone, osteocytes
may be regulating vascular growth within Intra-CB directly for improved nutrient transport to the
bone surface. On the other hand, these vasculature related genes may have been expressed by
vascular cells within Intra-CB, not osteocytes. Recent work has described a network of small
vessels that can transport nutrients and cells, including immune cells [12]. Intra-CB samples may
have contained enough transcortical vessels to reveal these changes.
The tissue samples we analyzed were micro-dissected from the postero-lateral tibial cortex,
a region that experiences compressive strain during axial tibial loading [94]. By analyzing this
small region, we reduced variability in the mechanical environment within samples; in particular,
we did not analyze tissues from the tensile cortex or the neutral axis. Nonetheless, the surface
cells in Mixed tissue samples experience fundamentally different mechanical stimuli than cells in
the Intra-CB region. Cells on the periosteal surface experience substrate strain as the bone
material deforms, whereas intracortical osteocytes experience a combination of substrate strain
and effects of fluid movement through the lacunocalicular network [35], [75]. Yet, we emphasize
that the transcriptional responses to loading reported here are not attributed solely to direct
mechanotransduction events at the individual cell level, but also to the effects of cell-cell
communication. In particular, signaling molecules from intracortical osteocytes may largely
orchestrate the response of the periosteal osteoblasts [142].
We found several challenges while conducting LCM in the mouse tibia. Due to the small
size of the tissue relative to the width of the laser beam, we were not able to compare Intra-CB
regions to more localized periosteal regions such as osteoblasts/bone lining cells. These
challenges also resulted in poor quality RNA in about half of the samples, resulting in low
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sample sizes and statistical power. Despite passing our quality control measures, degradation
might have biased the results towards more stable transcripts. Furthermore, microarrays have
their own disadvantages including a lower dynamic range compared to RNAseq. However, since
the concentrations and quality of our samples were not feasible for RNAseq, newer wholetranscriptome microarray technologies which incorporate amplification across the length of RNA
and do not require ribosomal depletion or poly-A selection, enabled our investigation into IntraCB specific gene expression.
In summary, LCM allowed analysis of loading-induced changes of osteocyte-enriched
tissue. We demonstrated for the first time an increase in expression of Ngf and Wnt1 by
osteocytes due to loading. We also showed an osteocyte-specific decrease in Mmp13 expression
due to loading which may implicate a decrease in perilacunar remodeling. Similarly, decreased
expression of osteoclast differentiation genes were apparent. Finally, vasculature processes were
enriched with loading in Intra-CB.
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3Chapter 3: Dmp1 Lineage Cells Contribute
Significantly to Periosteal Lamellar Bone
Formation Induced by Mechanical
Loading But Are Depleted From the Bone
Surface During Rapid Bone Formation
3.1 Abstract
The roles of osteoprogenitor cells (Prx1+) in the initiation (days 2-4 following the onset of
loading) [7]and sustainment (day 16 following the onset of loading) [143] of bone formation, and
preosteoblasts (Osx+) in the initiation (day 5 following the onset of loading) [1] of bone
formation have been demonstrated. However, the role of mature Dmp1-expressing osteoblasts in
bone formation has not been shown in vivo. In this study we investigated the role of Osx- and
Dmp1-expressing cells in loading-induced bone formation at an early timepoint following
mechaical loading (day 8 following the onset of loading). We utilized EdU in the drinking water
of inducible Osx and Dmp1 reporter mice (iOsx-Ai9, iDmp1-Ai9, respectively) from day 1 of
loading until sacrifice and pre-labeled Osx- and Dmp1-expressing cells with tamoxifen 3 weeks
before loading. We additionally loaded mice to lamellar- and woven- bone inducing stimulation
(-7 N/1400 µε, -10 N/2000 µε) to determine any differences in cellular mechanisms between
these types of bone formation processes. Despite strain-matching mice, we found varied
responses in males and females to the loading stimuli, inducing modest lamellar bone (females, 7 N), moderate lamellar bone (males, -10 N), and robust woven bone (females, -10 N). A
decrease in pre-existing Osx- and Dmp1-expressing cells at the bone surface occurred, with a
near depletion of Dmp1-expressing cells from the surface in female Dmp1 mice loaded to -10 N
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(52 to 11%). These cells appeared to be replaced by pre-existing Osx- from the periosteum. A
dose response in proliferation was observed, with 17-18% of bone surface cells arising via
proliferation in modest lamellar bone, 38-53% in moderate lamellar, and 59-81% in robust
woven bone. Overall, we showed that pre-existing Dmp1-expressing cells contribute largely to
the bone formation response, especially during modest bone formation, while other cells are
necessary to sustain the bone formation response during rapid bone formation.

3.2 Introduction
There are two classes of U.S. FDA approved anabolic therapies to treat advanced bone loss:
parathyroid hormone and its analogues, and sclerostin antibody [144]. But with these, there are
certain contraindications for use and limited periods of effectiveness. A better understanding of
the cellular mechanisms for initiating and maintaining bone formation may elucidate new
treatment strategies for bone loss.
Mechanical loading of murine animals has led to a better understanding of key molecular
and cellular events leading to bone formation in vivo [145]. Earlier studies identified
proliferation and activation of bone lining cells [146] as the cell source responsible for bone
formation [147], [148], although these studies were confounded by either invasive methods or
direct loading contacts on the periosteum. Uniaxial compressive loading in mice has alleviated
this problem and become the prevailing tool for understanding physiological bone formation in
vivo [56]. With this model, the importance of increased proliferation and activation has been
reported [1], [149] specifically in Osx-lineage cells [1] and in osteochondroprogenitors (Prx1+)
cells at the periosteal surface [7], [143].
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The differentiation stage of cells directly contributing to bone formation, and the role of
proliferation for the initiation and sustainment of bone formation have not been clearly defined.
Cabahug-Zuckerman et al. measured the presence of Prx1, Sca-1 and Ki67 markers within the
entire periosteum, showing an increase in Prx1+Sca1+/- proliferation on day 2 and 4, but not day 6
following the onset of loading to induce lamellar bone formation [7]. This technique is useful to
understand what is occurring overall in the periosteum, but the types of cells identified could not
be attributed directly to formation of bone at the surface. Moore et al. utilized an inducible Prx1
mouse to knock out periosteal osteoprogenitors [143]. Interestingly, this technique attenuated the
loading response in ulnae but did not entirely abrogate lamellar bone formation 15 days
following the start of loading. From these studies, it is clear that progenitor cells proliferate in the
periosteum following loading at early timepoints in lamellar bone formation, and
osteoprogenitors are necessary to sustain lamellar bone formation at later timepoints following
loading.
Zannit et al. showed that >95% of the lamellar bone forming periosteal surface was covered
by pre-existing Osx-lineage cells on day 5 following the onset of loading [1]. However, it is
unclear whether bone formation was generated by pre-osteoblasts, or cells later in the
differentiation pathway, because this reporter mouse marks cells at many stages of
differentiation. The Dmp1-Cre-ERT2;Ai9 (iDmp1-Ai9) mouse labels the most mature stage of
osteoblasts through osteocytes [66], [150], [151]. Using both the inducible Osx reporter and
iDmp1-Ai9 mice, we can better distinguish the role of preosteoblasts from mature osteoblasts.
Further, to investigate whether Osx-lineage cells continue to sustain bone formation past day 5,
we sought to evaluate bone formation at day 8 following loading. We suspected that the preexisting Osx and Dmp1 lineage cells are important for initiation of bone formation, and that
60

recruitment and differentiation of osteoprogenitors plays a greater role in sustaining the bone
formation response at later timepoints. Finally, these aspects of bone formation have not been
investigated in slower lamellar vs. more rapid woven bone formation, both of which can be
induced in a strain-dependent manner by in vivo loading. Thus, we chose two force levels to
induce lamellar and woven bone to examine differences in these processes.
Zannit et al. also observed some Osx-lineage cells embedded in newly formed matrix,
although these were not quantified [1]. Recent evidence suggests that osteocytes actively embed
into their matrix beginning with the simultaneous occurrence of Dmp1 expression and
mineralization [152], [153]. Thus, we used our model to investigate if pre-existing Dmp1
expressing cells are more likely to embed compared to cells earlier in the osteoblast lineage.
With this study we aim to determine the source of cells for bone formation at the periosteal
surface on day 8 following induction of either lamellar or woven bone formation in young-adult
mice. We utilize Osx and Dmp1 reporter mice to mark cells at different stages of differentiation
and a thymidine analog to detect proliferation occurring throughout the experiment. We quantify
cells in three distinct regions: directly on the bone surface, in the adjacent periosteum and in the
region of newly formed bone.

3.3 Methods
3.3.1 Mice
Transgenic Osx Cre-ERT2 (iOsx) [47] mice were provided by Henry Kronenberg (Harvard
University) for lineage tracing experiments. Mice were bred to Ai9 reporter mice that express the
TdTomato (TdT) fluorescent protein under the presence of Cre in the nucleus (#007909, The
Jackson Laboratory) [154] to produce iOsx-Ai9 reporter mice. The Osx-Cre-ERT2+/-;Ai9+/- (or +/+)
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offspring were used for conditionally labeling Osx-expressing cells upon administration of
tamoxifen (TAM; MilliporeSigma). Dmp1 Cre-ERT2 (iDmp1) mice [18] were provided by Paola
Pajevic (Boston University) for lineage tracing of osteoblast cells at a later stage in
differentiation. This inducible Dmp1 mouse utilizes the 10-kb fragment of Dmp1, which is
known to be expressed by osteocytes and some mature osteoblasts [18], [150], [155]. Similar
breeding schemes were utilized to generate Dmp1-Cre-ERT2+/-;Ai9+/- (or +/+) inducible reporter
mice (iDmp1-Ai9). For both reporter mice, Cre-;Ai9+/- (or +/+) mice were utilized to control for
any possible Cre effects. At approximately 4 months of age, mice were administered 75 mg/kg of
TAM daily for 5 days to pulse-label lineage cells. A 3-week clearance period was allowed before
loading to diminish any TAM effects (Figure 3.2A). Because TAM effects on bone formation
have been reported [156], [157], and due to leakiness of the Cre transgene under certain
promoters [66], [150], [155], TAM was withheld from a subset of mice (Cre+;Ai9+/- (or +/+)) as a
control. IACUC approval was obtained from Washington University before conducting animal
experiments.

3.3.2 Strain Gaging
At 5-months age, 27 mice were used for post mortem strain gage analysis (15 iOsx-Ai9; 12
iDmp1-Ai9) to estimate the peak forces for loading to generate anteromedial (tensile) strains of
1400 µε and 2000 µε. These strains correspond to approximately -2200 µε and -3200 µε peak
strains at the posterolateral surface (compressive), known to stimulate lamellar and woven bone,
respectively, in C57Bl/6 female mice [58]. Using methods previously described [94], strain
gages (FLK-1-11-1LJC, Tokyo Measuring Instruments Lab.) were applied to the tensile surface
of the tibia, and the tibia positioned in the same fixtures and subjected to the same loading
waveform used for in vivo loading (described below). Cyclic loads with peak forces ranging
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from -2 N to -8 N were applied using a materials-testing machine (DynaMight 8841, Instron).
The recorded strains were used to determine the force-strain relationship and to predict the peak
forces for generating the desired strains. Cre+ (n=4 iOsx-Ai9; n=3 iDmp1-Ai9) and Cre- (n=7
iOsx-Ai9; n=6 iDmp1-Ai9) mice were given tamoxifen while a subset did not receive tamoxifen
(n=4 iOsx-Ai9, n=3 iDmp1-Ai9). Because no trends due to Cre status or tamoxifen
administration were noticeable, Cre+ and Cre- mice were grouped together regardless of
tamoxifen administration.
Strain gaging analysis showed that -7 and -10 N peak forces would engender target strains
for producing lamellar and woven bone formation, respectively (Figure 3.1). Overall, similar
strains were produced at the chosen peak forces across mouse strain (iOsx-Ai9, iDmp1-Ai9) and
between sexes. However, slightly higher strains were induced by these forces in female iOsx-Ai9
mice (180-260 µε more than iOsx-Ai9 males).
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Figure 3.1: Similar strains were engendered by -7 N and -10 N peak forces across mouse strain and sex.
Force-strain relationship for (A) iOsx-Ai9 (males n=7; females n=8) and (B) iDmp1-Ai9 with respective linear
regression lines shown (males n=5; females n=7). (C) Linear regression equations for each group and the strains
produced by -7 N and -10 N. Higher strains (+180-260 me; +13%) were induced by these forces in female iOsx-Ai9
mice compared to males; whereas the slope of the corresponding linear regression lines were not different, the yintercepts were significantly different (p=0.0099).

3.3.3 Mechanical Loading
At 5-months of age, the chosen peak forces to stimulate lamellar and woven bone
formation were applied via force-controlled cyclic loading (Electropulse 1000, Instron) to the
right hindlimb. The tibia of each mouse was positioned between two fixtures holding the knee
and ankle in place so that a uni-axial force could be applied to the tibia. A -0.5 N pre-load was
used to keep the limb in place during loading. Sixty (60) cycles of a 4 Hz sinusoidal waveform
were applied daily for 5 days. Buprenorphine (0.1 mg/kg) was injected subcutaneously or
intraperitoneally (days 4 and 5 only) after each loading bout for pain management. Mice were
allowed free cage activity following loading. From the start of loading until sacrifice, mice were
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given a click chemistry thymidine analog (E10415, 5-ethynyl-2’-deoxyuridine, EdU; Thermo
Fisher Scientific) in their drinking water (0.2 mg/ml). Mice were group-housed by sex, but
controls without TAM were separated from others. Intraperitoneal (I.P.) injections of calcein
green (10 mg/kg, MilliporeSigma) were delivered on days 4 and 5 after loading; two closely
spaced doses were given to increase efficiency for marking a single-labeled surface. Mice were
allowed normal activity for 2 days after the last loading event and sacrificed on the third day
(Day 8). Mice were sacrificed by CO2 asphyxiation.

3.3.4 Dynamic Histomorphometry
A subset of mice were loaded to a peak force of -8 N (iOsx-Ai9 8 males, 5 females;
iDmp1-Ai9 7 males, 9 females) with the same loading protocol described above in order to
confirm an anabolic response in these transgenic lines (Figure 3.3A). These mice did not receive
EdU. Calcein green was injected (i.p.) on day 5 of loading. Mice were allowed cage free activity
for 1 week following the last loading bout. A second fluorochrome injection (alizarin
complexone, 30 mg/kg i.p.; MilliporeSigma) was delivered to the mice on day 10 and mice were
sacrificed on day 12 from the start of loading.
Samples were kept in 70% ethanol until ethanol gradation steps, then transitioned to xylene
and methyl methacrylate for plastic embedding. Samples were cut on a saw microtome (Leica) at
the desired maximal compressive region (~5 mm proximal to the tibiofibular junction). Sections
were cut transversely at approximately 100 µm thickness and polished with sandpaper to ~30 µm
thickness. Sections were imaged on an Axio Imager (Carl Zeiss) on the 10x objective. Images
were stitched together using Image Composite Editor (Microsoft). BIOQUANT OSTEO
software (Bioquant Imaging Analysis Corp.) was used to measure calcein and alizarin labels in
the samples according to standard histomorphometry guidelines [158]. For samples with no
65

apparent double label, 0.3 µm/day was used for MAR to compute BFR. Woven bone
mineralizing surface was added to MS/BS measures to compute total MS/BS, and woven area
thickness was used to modify MAR as described by Holguin et al. [58].

3.3.5 Histology
Non-loaded and loaded tibias were dissected from mice for lineage tracing. Muscle was
trimmed without disturbing periosteum. Bones were fixed in 4% paraformaldehyde for 24 hrs,
washed in PBS 3x, soaked in 30% sucrose for 2 days and optimal cutting temperature compound
(OCT, Tissue-Tek, VWR) for 1 day. Bones were embedded in OCT using a freezing plate and
sections were cut longitudinally on a cryostat at 6 µm thickness using Kawamoto film (SectionLab Co. Ltd). Sections were mounted to slides with 0.5% chitosan (419419, MilliporeSigma) in
0.25% acetic acid, and allowed to wick and dry for 2 days before staining.
Click-iT chemistry EdU staining was performed using Click It EdU Cell Proliferation Kit
for Imaging, Alexa Fluor 647 dye (C10340, Thermo Fisher) according to the user manual
instructions. DAPI counterstain was performed (D9452, MilliporeSigma) for 10 min. following
EdU staining. Sections were coverslipped using Fluoromount-G mounting media (00-4958-02,
Invitrogen, Thermo Fisher Scientific).

3.3.6 Imaging and Quantification
Sections were imaged on a Zeiss Axio Scan.Z1 slide scanner (Carl Zeiss) at 20x using
filters for DAPI, and green, red, and far-red fluorescent proteins. The ROI was selected by
measuring 5-mm from the tibial plateau and selecting a 2-mm long region including the muscle,
cortical bone and some marrow (Figure 3.2B). Images were exported as TIFF files and converted
to Bioquant Imaging Files (BIFs) using the correct resolution (0.325 µm/pixel). BIOQUANT
OSTEO was used to measure the bone surface length, calcein length, and to count individual
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cells. Cells within different regions of interest were counted separately. First, cells residing
between the calcein label and bone surface were counted as “new bone” cells. Next, cells
residing directly on the bone surface were counted as “bone surface” cells. Lastly, cells within
the periosteum between the first layer of bone surface cells and the muscle were counted as
“periosteal” cells. Each cell was identified as either TdT-EdU-, TdT+EdU-, TdT-EdU+, or
TdT+EdU+ to determine lineage specificity and whether the cell proliferated or was the product
of proliferation during the experiment.

Figure 3.2: Methods for ROI selection and quantification of cell type. (A) Timeline for lineage tracing
outcomes. (B) A 2 mm region of interest (ROI) was selected 5 mm distal to the tibial plateau. (C) Regions were
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divided into bone surface (i), new bone area (ii), and periosteum (iii). Cells were counted as TdT- EdU- (dark blue),
TdT+ EdU- (dark red), TdT- EdU+ (light blue), or TdT+ EdU+ (pink). Mu=Muscle, BS=Bone Surface, CB=Cortical
Bone.

3.3.7 Statistics
The majority of outcomes were tested for significance by two-way ANOVA with factors
being loading and force (GraphPad, Prism). Post-hoc Sidak tests with multiple comparison
corrections were used to determine significance between groups. Sex was not tested for
significance in lineage outcomes because of slight differences in strain stimulus and in observed
dynamic histomorphometry outcomes. Strain gaging data was analyzed by linear regression. For
certain outcomes, one-way ANOVA or t-tests were performed as appropriate and reported within
figure captions. Statistical significance was defined as p < 0.05, with non-significant differences
noted if p < 0.10.

3.4 Results
3.4.1 Modest to Robust Levels of Bone Formation Were Induced by Tibial
Loading in Reporter Mice
First, to assess bone formation in reporter mice we used classical dynamic
histomorphometry after loading to a peak force of -8 N. We observed increased bone formation
on the periosteal surface of loaded tibias, with some woven bone, in iOsx-Ai9 and iDmp1-Ai9
mice (Figure 3.3). Robust bone formation was induced by -8 N and the incidence of woven bone
formation (8/29) at this force indicated that -7 and -10 N were appropriate forces to generate
mostly lamellar and woven bone formation responses, respectively, for subsequent lineage
tracing experiments.
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Figure 3.3: Dynamic histomorphometry of iOsx-Ai9 and iDmp1-Ai9 mice loaded to -8 N. (A) Timeline for
dynamic histomorphometry protocol. (B-E) Representative images of (B-C) non-loaded and (D-E) loaded iOsx-Ai9
(males n=8; females n=5) and iDmp1-Ai9 (males n=7; females n=9) at site of peak compressive strain on day 12
following the onset of loading. (F-G) Periosteal mineralizing surface (Ps. MS/BS) quantified for (F) iOsx-Ai9 and
(G) iDmp1-Ai9. *p<0.05, Sidak post-hoc multiple comparisons test. Fractions in or near loaded bars indicate woven
incidence.
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While dynamic histomorphometry confirmed loading-induced bone formation, that was
based on a protocol that applied -8 N peak force, with samples collected 12 days after the onset
of loading, and analysis of double labels on 30 mm transverse plastic sections (Figure 3.3A). We
next analyzed bone formation from samples used for lineage tracing, which were loaded to -7 or
-10 N, collected on day 8, and analyzed based on a single calcein label on 6 mm longitudinal
cryo-sections (Figure 3.2A). In female mice, we observed a significant increase in calcein
labeled surface in both iOsx-Ai9 and iDmp1-Ai9 limbs loaded to -7 and -10 N (Figure 3.4).
Greater calcein label was apparent in female mice loaded to -10 N (iOsx-Ai9 93%, iDmp1-Ai9
91%) compared to -7 N (iOsx-Ai9 43%, iDmp1-Ai9 56%), consistent with a greater strain
stimulus. In contrast, in male mice, only -10 N loading increased calcein surface at this timepoint
in the region of interest. Calcein labeled 73% of the bone surface in male iOsx-Ai9 and iDmp1Ai9 mice loaded to -10 N. Notably, woven bone formation was apparent at this timepoint in 6/8
iOsx and 8/8 iDmp1 female mice loaded to -10 N, whereas no instances of woven bone were
observed in male mice. Thus, strain-matched loading induced a greater anabolic response in
female mice of both reporter lines.

70

Figure 3.4: Calcein was incorporated at the periosteal surface of loaded bones from most groups, indicating
increased mineralization in response to loading. Percentage of the bone surface that incorporated calcein into new
bone in iOsx-Ai9 (A) males (n=8/force) and (B) females (n=8/force) and in iDmp1-Ai9 (C) males (-7 N, n=7; -10 N,
n=8) and (D) females (n=8/force). *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 by Two-Way ANOVA repeated
measures, Sidak multiple comparisons correction (Factors: Loading, Force).

In addition to analysis of fluorochrome labels, we also quantified cell number at the bone
surface and within the periosteum (cells not directly on the bone surface) to detect whether
loading induced expansion of these cell populations. Only female mice loaded to -10 N
experienced an increase in cell number at the bone surface (iOsx-Ai9 14%, iDmp1-Ai9 19%)
(Figure 3.5). This effect was even greater in the periosteum, where female mice loaded to -10 N
experienced a 160% increase in cell number in iOsx-Ai9 mice and a 220% increase in iDmp1Ai9 mice. Taken together, these data demonstrate that our protocol induces modest (-7 N) and
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robust (-10 N) levels of bone formation in these mice using standard dynamic histomorphometry,
and samples directly used for subsequent lineage tracing.
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Figure 3.5: Loading induced an increase in cell number at the bone surface and periosteum. (A-D)
Quantification of total number of cells at the bone surface normalized to bone surface length in iOsx-Ai9 (A) males
and (B) females and iDmp1-Ai9 (C) males and (D) females. (E-H) Quantification of total number of cells within the
periosteum (not directly adjacent to the bone surface) normalized to bone surface length in iOsx-Ai9 (E) males and
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(F) females and iDmp1-Ai9 (G) males and (H) females. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 by TwoWay ANOVA repeated measures, Sidak multiple comparisons correction (Factors: Loading, Force).

3.4.2 TdTomato Was Leaky in 11% of Surface Cells of iDmp1-Ai9 Mice
Bones of iOsx-Ai9 and iDmp1-Ai9 mice should not show TdTomato expression unless
dosed with tamoxifen. As expected, in iOsx-Ai9 mice without TAM, TdT+ cells were rarely
found on the bone surface in non-loaded (0.3%) or loaded limbs (0.5%) (Figure 3.6). However,
in iDmp1-Ai9 mice without TAM, TdT+ cells were found in 11% of bone surface cells in nonloaded limbs, and 2% of cells in loaded limbs. No TdT+ cells were identified in Cre- mice. Thus,
there is modest leakiness in iDmp1-Ai9 mice, but this in not attributed to loading.
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Figure 3.6: TdTomato leakiness in iOsx-Ai9 and iDmp1-Ai9 mice. (A-B) Representative images of leakiness of
(A) iOsx-Ai9 and (B) iDmp1-Ai9 mice without tamoxifen administration in non-loaded limbs. (C) Representative
image of a Cre- mouse where no TdT+ cells were found on the bone surface. (D-E) Quantification of the number of
TdT+ cells on the bone surface normalized to total number of bone surface cells in (D) iOsx-Ai9 and (E) iDmp1-Ai9
mice that did not receive tamoxifen. **p<0.01 by paired t-test. Male and female data combined. No tamoxifen:
iOsx-Ai9 total n=6 (males n=3, females n=3); iDmp1-Ai9 total n=8 (males n=4, females n=4). Cre Negative: iOsxAi9 total n=6 (males n=3, females n=3); iDmp1-Ai9 total n=7 (males n=4, females n=3).

3.4.3 Pre-existing Osx-lineage Cells Are a Primary Source of Cells for -7 N
Loading Stimulus but Play Less of a Role in Maintaining Bone
Formation for -10 N Stimulus
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The percentage and number of TdT+ cells at the bone surface in male and female iOsx-Ai9
mice did not change with loading to -7 N, but was diminished in female mice loaded to -10 N
(Figure 3.7). Approximately 65% of cells on the non-loaded bone surface of males and females
were TdT+. These cells persisted on the surface with loading in male mice, regardless of force. A
similar persistence of TdT+ cells on the bone surface occurred in female mice loaded to -7 N. In
contrast, in female mice loaded to -10 N there was a 29% decrease in the number of TdT+ cells
on the bone surface of loaded versus non-loaded tibias (41 vs. 65%; 29 vs. 41 cells/mm). Thus,
after a higher load stimulus (-10 N) that induced woven bone in female mice, there is a depletion
of pre-existing Osx-lineage cells on the bone surface, suggesting replacement by newly
differentiated osteoblasts.
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iOsx-Ai9 TdT+ cells to bone formation. (A-H) Representative
images of iOsx-Ai9 (A,B) Non-loaded limbs, (C,D) female limbs loaded to -7 N, (E,F) male
limbs loaded to -10 N, and (G,H) female limbs loaded to -10 N. (I-L) Quantification of TdT+
cells at the bone surface in iOsx-Ai9 (I,J) males and (K,L) females. *p<0.05, **p<0.01,
***p<0.001, ****p<0.0001 by Two-Way ANOVA repeated measures, Sidak multiple
comparisons correction (Factors: Loading, Force). BS=Bone Surface, Mu=Muscle, CB=Cortical
Bone.
Figure 3.7: Contribution of
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3.4.4 Pre-existing Dmp1-lineage Cells Are a Primary Source of Cells for -7 N
Loading Stimulus But Are Depleted Markedly on Day 8 Following -10 N
Loading
Similar to iOsx-Ai9, the percentage and number of TdT+ cells at the bone surface of
iDmp1-Ai9 mice were similar in non-loaded and loaded limbs at -7 N, but these cells decreased
by day 8 in limbs loaded to -10 N (Figure 3.8). In non-loaded limbs, TdT+ cells made up
approximately 50% of cells at the bone surface. No change in percentage or number of TdT+
cells at the surface occurred in either male or female mice loaded to -7 N. In contrast, in males
loaded to -10 N there was a 31% decrease in the number of TdT+ cells on the surface of loaded
versus non-loaded tibias (30% vs. 48%; 22 vs. 32 cells/mm). A more pronounced effect was
found in female mice loaded to -10 N, resulting in a 78% decrease in the number of TdT+ cells at
the bone surface of loaded versus non-loaded tibias (11 vs. 52%, 8 vs. 33 cells/mm). Thus, after a
potent loading stimulus (-10 N) that induces robust bone formation, there is a depletion of preexisting Dmp1-lineage cells on the bone surface that is more pronounced than the depletion of
Osx-lineage cells.
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Figure 3.8: Contribution of iDmp1-Ai9 TdT+ cells to bone formation. (A-H) Representative images of iDmp1Ai9 (A,B) Non-loaded limbs, (C,D) female limbs loaded to -7 N, (E,F) male limbs loaded to -10 N, and (G,H)
female limbs loaded to -10 N. (I-L) Quantification of TdT+ cells at the bone surface in iDmp1-Ai9 (I,J) males and
(K,L) females. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 by Two-Way ANOVA repeated measures, Sidak
multiple comparisons correction (Factors: Loading, Force). BS=Bone Surface, Mu=Muscle, CB=Cortical Bone.
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3.4.5 Proliferation Contributes More To The Bone Surface Population at -10
N Loading Stimulus
At the bone surface, cell proliferation was stimulated by loading in male mice loaded to 10 N and female mice loaded to either force (Figure 3.9, A-D). Of these groups, female mice
loaded to -7 N experienced the least proliferation of cells on the bone surface (17% iOsx-Ai9,
18% iDmp1-Ai9). Proliferation contributed more at the higher (-10 N) force level in male mice
(38% iOsx-Ai9, 53% iDmp1-Ai9) and female mice (59% iOsx-Ai9, 81% iDmp1-Ai9). Similar
trends were observed in number of EdU+ cells per bone surface, with the maximum number of
EdU+ cells occurring in iDmp1-Ai9 female mice loaded to -10 N (62 cells/mm) (Figure 3.10, AD).
Some of the cells that arose via proliferation were progeny of lineage positive cells (Figure
3.9, E-H). On tibias from iOsx-Ai9 female mice loaded to -7 N, 10% of bone surface cells were
TdT+EdU+. On tibias loaded to -10 N, TdT+EdU+ cell contribution was 16% in female iOsx-Ai9
mice and 18% in male iOsx-Ai9 mice. Less contribution of TdT+EdU+ cells to the bone surface
was observed in loaded limbs of iDmp1-Ai9 mice. No change occurred in males loaded to -7 N,
but a trend towards an increase occurred in female mice (p=0.08). Male iDmp1-Ai9 mice loaded
to -10 N experienced an increase to 9% while an increase in TdT+EdU+ cells in female iDmp1Ai9 mice loaded to -10 N did not occur. Similar effects occurred in number of TdT+EdU+ cells
normalized to bone surface length, with the maximum number of cells occurring in iOsx-Ai9
male mice loaded to -10 N (13 cells/mm) (Figure 3.10, E-H).
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Figure 3.9: Contribution of proliferation to bone surface cell population. (A-D) Total percentage of bone
surface cells that proliferated or arose via proliferation (EdU +) in iOsx-Ai9 (A) males and (B) females, and iDmp1Ai9 (C) males and (D) females. (E-H) Percentage of cells on the bone surface that that proliferated or arose via
proliferation from a lineage positive cell (TdT+EdU+) in iOsx-Ai9 (E) males and (F) females, and iDmp1-Ai9 (G)
males and (H) females. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 by Two-Way ANOVA repeated measures,
Sidak multiple comparisons correction (Factors: Loading, Force).
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Figure 3.10: Number of proliferative cells per bone surface induced by loading. (A-D) Total number of bone
surface cells arisen via proliferation (EdU+) in iOsx-Ai9 (A) males and (B) females, and iDmp1-Ai9 (C) males and
(D) females. (E-H) Number of cells on the bone surface that arose via proliferation from a lineage positive cell
(TdT+EdU+) in iOsx-Ai9 (E) males and (F) females, and iDmp1-Ai9 (G) males and (H) females. *p<0.05,
**p<0.01, ***p<0.001, ****p<0.0001 by Two-Way ANOVA repeated measures, Sidak multiple comparisons
correction (Factors: Loading, Force).
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Of the cells that were lineage positive on the bone surface, the percentage that
proliferated or arose via proliferation was greatest in female mice loaded to -10 N (41% iOsxAi9, 46% iDmp1) (Figure 3.11). However, as noted above (Figure 3.9) the total number of TdT+
cells in these limbs was low (29 TdT+ cells/mm iOsx-Ai9, 8 TdT+ cells/mm iDmp1-Ai9). Thirty
percent (30%) of TdT+ cells arose via proliferation at the bone surface in male mice loaded to -10
N (43 TdT+ cells/mm iOsx-Ai9, 22 TdT+ cells/mm iDmp1-Ai9). Finally, a small portion of TdT+
cells in iOsx-Ai9 female mice loaded to -7 N arose via proliferation (15%, 43 TdT+ cells/mm).
Taken together, the results show that proliferation at the bone surface increased with increasing
applied force (strain), and that many lineage-positive cells (15-46%) proliferated or arose via
proliferation.

Figure 3.11: Percentage of lineage positive cell that arose via proliferation. Percentage of TdT+ cells on the bone
surface that were co-labeled with EdU in iOsx-Ai9 (A) males and (B) females, and iDmp1-Ai9 (C) males and (D)
females. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 by Two-Way ANOVA repeated measures, Sidak multiple
comparisons correction (Factors: Loading, Force).
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3.4.6 In Tibias Loaded to -10 N, the Majority of Newly Embedded Cells are
TdT+
Cells located between the calcein label (day 5) and the bone surface (day 8) were
interpreted as newly embedded osteoblasts/osteocytes. A negligible number of newly embedded
cells were observed in mice loaded to -7 N, while a few cells (13-16 cells/mm) were found that
embedded in this region in male mice loaded to -10 N (Figure 3.12). In male mice loaded to -10
N, the majority of embedded cells were TdT+ (84% iOsx-Ai9, 85% iDmp1 -Ai9); these
proportions were comparatively higher than the percentage of lineage-positive cells on the bone
surface of non-loaded limbs (68% iOsx-Ai9; 48% iDmp1-Ai9; Figure 3.7I, Figure 3.8I). Female
mice loaded to -10 N, which had the highest proportion of woven bone, had by far the greatest
number of cells embedded (66 cells/mm iOsx-Ai9, 144 cells/mm iDmp1-Ai9). These mice also
had a high proportion of lineage-positive embedded cells (61% iOsx-Ai9, 43% iDmp1-Ai9);
these proportions are comparable to the percentage of lineage-positive cells in non-loaded limbs
(65% iOsx-Ai9; 52% iDmp1-Ai9; Figure 3.7K, Figure 3.8K). Thus, lineage-positive cells are the
main source of newly embedded cells, especially for lamellar bone formation.
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Figure 3.12: Cell population within newly formed bone. (A-D) Number of cells that were incorporated into new
bone, normalized to bone surface length in iOsx-Ai9 (A) males and (B) females, and iDmp1-Ai9 (C) males and (D)
females. (E-H) Percentage of embedded cells in mice loaded to -10 N that are TdT+ in iOsx-Ai9 (E) males and (F)
females, and iDmp1-Ai9 (G) males and (H) females. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 by unpaired ttest.

3.4.7 The Periosteum is Composed Primarily of TdT- Cells that are More
Proliferative at -10 N Loading Stimulus
Within the periosteum (cells not directly on the bone surface), the majority of cells were
lineage negative (Figure 3.13, A-D). TdT+ cells comprised only 6-17% of the periosteum in nonloaded limbs of iOsx-Ai9, and 7-18% in iDmp1-Ai9 mice. Loading caused a decrease in
percentage of TdT+ cells in the periosteum of female iDmp1-Ai9 mice loaded to -10 N (nonloaded 18%, loaded 3%). However, this group experienced the greatest increase in total number
of cells/mm in the periosteum (216% increase).
There were few proliferative cells in non-loaded limbs (average EdU+/Total < 5%; Figure
3.13, E-H). Loading stimulated increases in periosteal proliferation only in mice loaded to -10 N.
The percentage of cells that were EdU+ in male mice loaded to -10 N increased to 33% in iOsxAi9 mice and 45% in iDmp1-Ai9 mice. An even greater portion of cells were EdU+ in female
mice loaded to -10 N (iOsx-Ai9 56%, iDmp1-Ai9 58%). Thus, the majority of periosteal cells are
not committed to the Osx or Dmp1 lineage, and a proportion are induced to proliferate upon
loading, especially at higher forces.
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Figure 3.13: Periosteum lineage positive population and proliferative response with loading. (A-D) Percentage
of periosteal cells that are TdT+ in iOsx-Ai9 (A) males and (B) females, and iDmp1-Ai9 (C) males and (D) females.
(E-H) Percentage of periosteal cells that are EdU+ in iOsx-Ai9 (E) males and (F) females, and iDmp1-Ai9 (G)
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males and (H) females. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 by Two-Way ANOVA repeated measures,
Sidak multiple comparisons correction (Factors: Loading, Force).

3.5 Discussion
Few studies have investigated the differentiation stage of cells contributing to bone
formation induced by mechanical loading, despite many advances in lineage tracing tools,
imaging techniques, and loading models for in vivo use. Recent studies have identified roles for
osteoprogenitors (Prx1+) [7], [143], but whether these cells contribute directly to the bone
forming surface, and whether they are important for initiating bone formation vs. sustaining the
response is unclear. Others have shown that more differentiated cells (Osx-lineage) contribute to
the initial bone formation response (day 5 of lamellar loading) [1], but this reporter mouse marks
cells in several stages of differentiation. We sought to clarify the role of pre-existing Osx
expressing cells in sustaining the bone formation response at day 8 of lamellar loading. We also
investigated the role of mature osteoblasts via the iDmp1-Ai9 mouse to better distinguish the
population of cells contributing to bone formation. We found that pre-existing Osx and Dmp1
lineage cells were the predominate contributors to modest lamellar bone formation, but their
contribution diminished for more moderate lamellar and robust woven bone formation.
We designed our study to extend the prior work on lineage tracing after bone loading. We
loaded male and female mice to two forces (-7 N, -10 N), which allowed us to generate three
degrees of bone formation: modest lamellar, moderate lamellar, and robust woven. The degrees
of bone formation in iOsx-Ai9 and iDmp1-Ai9 reporter mice were similar. Labeling of calcein at
the initiation of bone formation was found to be important for interpretation of type of bone
formation present in each sample. Finally, continuous EdU administration during this time period
showed a dose response in terms of proliferation contributing to cell source with increasing
degrees of bone formation. Notably, we also found small contributions of Osx and Dmp1 lineage
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cell proliferation to the bone forming surface, although their contribution did not increase with
more bone formation in a dose dependent manner and remained below 20% of total cells at the
bone surface.
The types of bone formation that occurred in the groups analyzed in this study were of a
modest lamellar type (females loaded to -7 N), a moderate lamellar type (males loaded to -10 N)
and a robust woven type (females loaded -10 N) (Figure 3.14). In the first scenario, cells can be
found residing directly atop calcein surface, similar to results found by Zannit et al. where preexisting Osx-lineage cells contributed to >95% of the bone surface in loaded limbs [1]. The
modest stimulation appears to activate cells already at the bone surface, which are mostly Osx+
and Dmp1+ cells. No increases in cell number, and a modest increase in proliferation (17-18%)
were found at this stage. Zannit et al. found approximately 30% of the bone surface cells arise
via proliferation on day 5 of loading using a similar continuous administration of a thymidine
analogue [1]. In the second scenario, a balanced exchange of cells takes place between the
periosteum, bone surface, and new bone region. Dmp1+ cells appear to be poised to embed into
newly formed bone between calcein and the bone surface, causing a decrease in TdT+ cells at the
bone surface. However, no overall change in cell number occurs. Thus, cells that embed are
replaced by TdT- cells via proliferation (38-53% EdU+) and/or recruitment from the periosteum.
In the last scenario, a highly cellular region appears below the bone surface. This region has
many cell types, while few Dmp1+ cells remain at the bone surface (<10%) following this type of
bone formation. Unlike the other cases, an increase in cell number at the surface and in the
periosteum occurs, composed primarily of TdT- cells (>90%). The new bone region has woven
bone characteristics with regions densely occupied by TdT- cells, consistent with bone marrow.
Overall, it appears the depletion of pre-existing Osx and Dmp1 lineage cells, primarily Dmp1
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lineage cells, occurs and that these cells are replaced at the surface by presumably less
differentiated cells. These cells could be of Prx1 lineage, supporting work by Moore et al. [143]
and Cabahug-Zuckerman [7].

Figure 3.14: Model depicting bone formation responses to loading. (A) A major component of the quiescent
bone surface includes mature, Dmp1 lineage cells. (B) Modest stimulation induces lamellar bone formation
characterized by a thin calcein layer near the bone surface, with Dmp1 lineage cells contributing to the majority of
the response. Some proliferation occurs at the bone surface. (C) Moderate stimulation induces lamellar bone
formation with a thicker area of new bone between the calcein label and bone surface. Proliferation of less
differentiated cells contributes to this response (TdT-EdU+). Dmp1 lineage cells decrease at the bone surface, while
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these cells can be found populating the new bone region. (D) Robust stimulation induces woven bone formation
characterized by circular regions of high cellularity (outlined in white), an expansion of the periosteum, increased
cell number at the bone surface, and many cells in the new bone area. The bone surface is nearly depleted of Dmp1
lineage cells.

Although iOsx-Ai9 and iDmp1-Ai9 mice reportedly mark cells beginning at earlier and
later stages of differentiation [47], [62], [66], [150], [151], respectively, we found many
similarities between the labeling of cells in these models. Specifically, iOsx-Ai9 only labeled
~10% more cells compared to iDmp1-Ai9 in non-loaded tibias. This suggests that the majority of
cells (48-56%) on the quiescent bone surface are mature osteoblasts. Others have also reported
labeling on the bone surface in iDmp1-Ai9 mice, but not to this extent [66], [150], [151].
Differences in timing and dosages of tamoxifen, clearance periods, and ages of mice are known
to effect the degree of TdT expression [66], [150]. The percentage of cells marked by Osxlineage on day 8 in this study were ~25% fewer than in non-loaded tibias on day 5 of loading
found in Zannit et. al [1]. Importantly, we also found the iOsx-Ai9 mouse line used here to be
less leaky compared to others, with fewer than 1% labeled on the bone surface while Zannit et al.
reported 20% of cells on the surface labeled without tamoxifen administration. We note that the
iOsx-Ai9 mouse line used here was started by mating new OsxCreERT2 and Ai9 breeders, and
was different from the line used by Zannit et al. The decreased percentage of cells of Osx lineage
found in this study could be due to a less leaky reporter, a less efficient reporter, or a difference
in time since tamoxifen administration which was extended by 3 days in this study.
Calcein labeling at the initiation of bone formation (day 4 and 5 of loading) was
important in identifying the degree and type of bone formation in this study, and revealed
differences between sexes. Although the force-strain relationships for males and females were
very similar, we found varied responses noticeable by extent of new bone formation between the
calcein label and new bone surface. This difference was also exemplified by percentage of
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surface labeled with calcein in the region of interest; 0% for males loaded to -7 N, 43-56% for
females loaded to -7 N, 73% for males loaded to -10 N, and 91-93% for females loaded to -10 N.
These differences were also reflected by standard dynamic histomorphometry at day 12
following the start of loading, but the differences were not quite as striking. While our strain
gaging data demonstrated similar strains in male and female mice, others have shown that female
mice experience more strain per a given force compared to males [159]. Few studies investigate
differences between male and female mice, although Meakin et al. did show differences in bone
response to loading in female and male mice with age, suggesting that these differences may
increase or change with age [160]. Identification of type of bone formation within the samples
analyzed at this particular timepoint was important for interpretation of the results. For instance,
at this timepoint 6/8 and 8/8 females loaded to -10 N formed woven bone while males loaded to
the same force (and strain stimulus) were not actively forming woven bone. Results are
presented here as differences in degrees of bone formation occurring, but these differences might
be in part driven by differences in how males and females respond to the same strain stimulus.
In summary, our results show predominant contributions by pre-existing Osx and Dmp1
lineage cells to loading-induced bone formation, especially for lamellar bone formation.
However, this work demonstrates that recruitment of other cells is necessary for sustaining the
bone formation response at day 8, especially for more robust types of bone formation, like
woven bone. It remains to be shown if TdT+ cells become completely depleted from the bone
surface over longer periods. Importantly, we found large differences in responses in male and
female mice despite strain-matched stimuli although this allowed an analysis of varied bone
formation responses. Future studies may improve upon past work by individualizing peak force
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for each mouse. Whether these mechanisms are altered by aging should also be addressed in
future studies.
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4Chapter 4: Lineage Tracing of Osteoblast
Lineage Cells in Young-Adult and Old
Mice Following Mechanical Loading
4.1 Abstract
The cellular mechanisms for mechanical loading-induced bone formation in young-adult
mice are not well understood. A better understanding of the cell-types and role of proliferation in
bone formation, and any differences between young-adult and aged mice would aide in the
discovery of new anabolic therapies to treat diseases like osteoporosis. Previous work has shown
that Osx and Dmp1 expressing cells contribute to the early bone formation response (day 5 and 8
following the onset of loading) [1] (Chapter 3). However, the importance of these cells at later
stages of bone formation and in old mice has not been investigated. Thus, we conducted strainmatched lineage tracing experiments with inducible Osx and Dmp1 Cre reporter mice at 5 mo
and 22 mo to determine the roles of preosteoblasts and mature osteoblasts to the sustainment of
bone formation. Osx- and Dmp1-expressing cells were labeled with tamoxifen before loading for
5 days, and EdU was administered to the drinking water of mice from the start of loading until
sacrifice on day 12 to label any proliferating cells. The number of pre-existing Osx- and Dmp1expressing cells as well as the cells arising via proliferation were quantified on the bone surface,
within newly formed bone, or in the adjacent periosteum. We found significant decreases in the
number of pre-existing Osx-expressing cells on the bone surface following loading in 5 mo mice
(63% to 40%), but not 22 mo mice (remained ~70%). In contrast, both 5 mo and 22 mo mice
experienced a decrease in Dmp1-expressing cells at the bone surface following loading (51% to
25%, and 59% to 26%, respectively). Thus, preosteoblasts continue to sustain the bone formation
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response in aged mice up to 12 days following the onset of loading, but pre-existing progenitor
cells may play more of a role in 5 mo mice. Proliferation contributed largely to bone formation
(37-62% of the bone surface), with no deficits found in aged mice. We also demonstrated a
greater percentage in the new bone region of pre-existing Osx- and Dmp1-expressing cells (6788%) compared to the bone surface (51-73%), with no differences in aged mice, suggesting a
tendency for mature osteoblasts to embed. We conclude that young-adult and aged mice utilize
similar mechanisms for loading-induced bone formation, but a greater portion of the periosteum
of aged mice are committed osteoblasts which may eventually cause declines in bone
mechanoresponsiveness as they continue to sustain bone formation.

4.2 Introduction
A predicted 2 million fractures were estimated in the U.S. in 2005, costing close to $17
billion [161]. Low bone mass, or osteoporosis is associated with fracture risk [162], where in the
U.S., the prevalence of osteoporosis in 2017-2018 was estimated to be 19.6% in women aged
≥50 years [163]. Mechanical loading, or exercise, is known to increase bone mass [25], [26], but
the benefits of exercise in older individuals have been inconclusive [164]–[166]. Progress has
been made in understanding the mechanisms for loading induced bone formation in young-adult
and aged animals, but there is still much unknown about the cellular responses to loading.
Several studies have shown that aged mice have increased total bone area [167]–[169],
mineralization and crystallinity [167], and porosity [169], and decreased cortical thickness [94],
[169]. These properties contribute to differences in strain magnitudes throughout the aged bone.
In particular, aged mice have been shown to exhibit reduced strains [170], and a dysregulation in
formation or resorption responses to medium strain stimuli [171]. Despite these age related
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differences, mice have been shown to respond to mechanical loading, albeit at a reduced capacity
[7], [58], [160], [172].
Several mechanisms have been implicated for this diminished response to loadinginduced bone formation. Deficiencies in osteocyte cell network have been shown, including
decreased dendrite number and cell density which may lead to diminished mechano-sensation
and transduction [169]. Holguin et al. identified an impaired ability to sustain SOST
downregulation and Wnt signaling following initial responses to loading [81]. The proliferative
response of osteoblast precursors have also been shown to be attenuated with age, by PCNA and
Ki-67 staining following mechanical loading [7], [160]. However, other techniques including
continuous labeling of proliferative cells throughout loading experiments have shown similar
upregulation in young-adult (5-mo) and middle-aged (12-mo) mice [1], [80]. Additionally,
ablation of proliferating osteoblasts greatly diminishes the bone formation response of both
young-adult and middle-aged mice [149].
Lastly, recent work by Zannit et al. has indicated that Osx-expressing osteoblasts are
activated at the bone surface to form bone in young-adult and middle-aged mice to a similar
degree [1]. The Osx reporter mouse used by Zannit and colleagues marks cells from preosteoblasts to fully mature osteoblasts and even osteocytes. Thus, it is unclear if there is a deficit
in more differentiated osteoblasts in aged mice at bone forming sites. The Dmp1-Cre-ERT2;Ai9
mouse demarcates cells that are fully differentiated osteoblasts through osteocytes. Dmp1 has
been shown to be expressed in close proximity to mineralizing bone nodules by transitioning
osteocytes [152]. Due to the importance of these mature, transitioning osteocytes in
mineralization [48], [152], [153], [173], we sought to investigate their role in bone formation in
young-adult and aged mice.
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In this study, we utilize lineage tracing techniques with an Osx and Dmp1 reporter to
detect differences in the recruitment of cells at various stages of differentiation. Extending
previous work, we investigate bone formation at a later timepoint (day 12), and compare
outcomes in young-adult and aged mice. We also incorporate proliferation labeling by EdU
administration throughout the experiment to determine any differences in cumulative
contribution of proliferation to cell recruitment. We expected to observe differences in lineage
and proliferation in cells residing at bone forming surfaces.

4.3 Methods
4.3.1 Mice
Tamoxifen (TAM) inducible Osx-Cre-ERT2+/-;Ai9+/- (or +/+) (iOsx-Ai9) and Dmp1-CreERT2+/-;Ai9+/- (or +/+) (iDmp1-Ai9) mice were generated by crossing the inducible Cre mice
(provided by Henry Kronenberg and Paola Pajevic, respectively) to TdTomato (TdT/Ai9)
reporter mice (#007909, The Jackson Laboratory). Tamoxifen was delivered to experimental
animals by i.p. injection (75 mg/kg, MilliporeSigma) for 5 days at approximately 4 months or 21
months of age. A 3-week clearance period before mechanical loading was allowed to minimize
any tamoxifen effects on bone formation [156], [157]. Thus, mice were 5-mo (young-adult) or
22-mo (old) at the time of loading and lineage tracing. A subset of mice were used to determine
the leakiness of the Cre reporters at both ages, in which tamoxifen was not delivered to mice
[66], [150], [155]; Cre-;Ai9+/- (or +/+) were also used to control for any Cre effects. Animal
experiments were approved by Washington University IACUC before any experiments were
conducted.
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4.3.2 Strain Gaging
A total of 19 iOsx-Ai9 (n = 11 males, n = 8 females) and 9 iDmp1-Ai9 (n = 4 males, n = 5
females) 22-mo old mice were strain gaged to determine force-strain relationships, which were
used to strain match the groups used for lineage tracing (Figure 4.1). A mix of tamoxifen treated
and Cre+/- mice were utilized. Strain gages (FLK-1-11-1LJC, Tokyo Measuring Instruments
Lab.) were applied and strains were recorded as described by others [94] using a materialstesting machine (DynaMight 8841, Instron). To induce a target tensile strain of 1600 µε (-2560
µε compressive), a force of -16 N was required for 22-mo old male mice (both iOsx-Ai9 and
iDmp1-Ai9). Forces of this magnitude may cause joint injury and unwanted inflammatory
effects, so we did not use aged males in this study. Aged female bones were also stiffer than
previously reported young-adult mice of the same mouse line (Chapter 3). However, the forces
required to generate 1600 µε were only -9 N (iOsx-Ai9) and -11.5 N (iDmp1-Ai9). Thus, only
female aged mice were used for subsequent loading experiments. To generate 1600 µε, 5 mo
males and females were loaded to -8 N based on linear regression equations reported in Chapter
3. The strains induced by -8 N peak force for iOsx-Ai9 were 1613 µε (males) and 1832 µε
(females) and for iDmp1-Ai9, peak strains were 1521 µε (males) and 1562 µε (females).
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Figure 4.1: Aged (22 mo) mice were strain gaged to determine peak loading force for matched stimuli. (A-B)
Strain-force relationship for (A) iOsx-Ai9 (n = 11 males, n = 8 females) and (B) iDmp1-Ai9 mice (n = 4 males, n =
5 females). (C) Linear regression equations (slopes significantly different) and respective strains induced by the
chosen force levels. Data for 5 mo mice also shown in Chapter 3.

4.3.3 Dynamic Histomorphometry
A subset of aged female Cre- mice (iOsx-Ai9 n=4; iDmp1-Ai9 n=7) were loaded for
standard dynamic histomorphometry analysis (Figure 4.2A). A mix of tamoxifen treated mice
were utilized. iOsx-Ai9 and iDmp1-Ai9 mice were loaded to peak forces of -9 N and -11.5 N,
respectively. A sinusoidal waveform (4 Hz, 60 cycles) was applied daily for 5 days using an
Electropulse loading device (Instron Electropulse 1000, Instron). Mice were injected (i.p.) with
calcein green (10 mg/kg, MilliporeSigma) on day 5 from start of loading and with alizarin red
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(alizarin complexone, 30 mg/kg; MilliporeSigma) on day 10. Buprenorphine (0.1 mg/kg) was
injected subcutaneously to minimize pain following each loading bout. Sacrifice by CO2
asphyxiation occurred on day 12. Standard protocols for dynamic histomorphometry were used
for processing samples. Samples were imaged on a Axio Imager (Carl Zeiss) microscope at 10x
and the entire periosteal surface was analyzed using BIOQUANT OSTEO software (Bioquant
Imaging Analysis Corp.). Woven bone was incorporated into measurements using a modified
mineral apposition rate (MAR) as described by Holguin et al. [58]. The endosteal surface was
not analyzed.

4.3.4 Lineage Tracing
A total of 19 iOsx-Ai9 female mice (5 mo, n=8; 22 mo; n=11), 17 iDmp1-Ai9 female
mice (5 mo, n=8; 22 mo, n=9), and 17 young-adult males (iOsx-Ai9 n=8, iDmp1-Ai9 n=9) were
loaded for 5 days following tamoxifen treatment and a 3-week clearance period (Figure 4.3A).
To label proliferating cells throughout the experiment, 5-ethynyl-2’-deoxyuridine (EdU; E10415,
Thermo Fisher Scientific) was delivered to mice daily via drinking water (0.2 mg/ml EdU, 5%
sucrose). Calcein was injected (s.c.) to mark the initiation of bone formation on days 4 and 5 of
loading and near the end of the bone formation period (day 9). Buprenorphine (0.1 mg/kg) was
injected subcutaneously or by i.p. (days 4 and 5 only) for analgesia following each loading bout.
Mice were sacrificed by CO2 asphyxiation on day 12.
As described elsewhere in Chapter 3.3, loaded and contralateral limbs were dissected and
processed for frozen undecalcified sectioning (5 µm thick) using Kawamoto film (Section-Lab
Co. Ltd). Sections were stained for EdU using the Click It EdU Cell Proliferation Kit for
Imaging, Alexa Fluor 647 dye (C10340, Thermo Fisher). A 10 min. DAPI counterstain (D9452,
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MilliporeSigma) was applied to sections and fluoromount-G mounting media (00-4958-02,
Invitrogen, Thermo Fisher Scientific) was used to coverslip sections.
A Zeiss Axio Scan.Z1 slide scanner (Carl Zeiss) was used to image histological slides on
a 20x objective using DAPI, and a green, red, and far-red fluorescent protein filters. As described
in Chapter 3.3, a region of interest (ROI) 5 mm distal to the tibial plateau was selected for
analysis. A 2 mm longitudinal image of the periosteal surface was exported for quantification
using BIOQUANT OSTEO software. The same methods for quantification presented bin
Chapter 3.3 were used, including separation of analysis into three regions: cells directly on the
bone surface (bone surface cells), cells within the periosteum between this bone surface layer
and the muscle (periosteal cells), and cells between the first calcein label and the bone surface
(new bone cells). Cells were identified based on expression of each of the fluorescent labels
marking lineage specificity and EdU incorporation (TdT-EdU-, TdT+EdU-, TdT-EdU+, or
TdT+EdU+). Quantifications was done by a single, blinded reader. The endocortical surface was
not analyzed.

4.3.5 Statistics
Strain gaging linear regression tests were performed to determine significant differences
between males and females in force-strain relationships. For most outcomes, female 5 mo and 22
mo mice were analyzed by Two-Way ANOVA with repeated measures and Sidak multiple
comparisons correction with loading and age as the independent factors. Data for iOsx-Ai9 and
iDmp1-Ai9 mice were analyzed separately. Outcomes for males were analyzed by paired t-tests.
Significance was defined as p < 0.05, with trends noted at p < 0.10.
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4.4 Results
4.4.1 Loading Stimulates Periosteal Bone Formation in Young-Adult and
Aged Mice To A Similar Degree
Dynamic histomorphometry showed strong stimulation of bone formation on the periosteal
surface in 5 mo and 22 mo mice (Figure 4.2). Despite similar strain stimuli in 22 mo iOsx-Ai9
(1595 µε) and iDmp1-Ai9 (1580 µε) mice, greater mineralizing surface (MS/BS) was found in
iDmp1 mice (80%) compared to iOsx (50%) and more bones were stimulated to form woven
bone in 22 mo iDmp1-Ai9 mice (5/7) compared to iOsx-Ai9 (1/6). MAR was also higher in
iDmp1-Ai9 mice (3.4 µm/day) compared to iOsx-Ai9 (2.1 µm/day). In Chapter 3, we showed
that 5 mo female iOsx-Ai9 mice loaded to -8 N generated 67% MS/BS and iDmp1-Ai9 female
mice generated 65% MS/BS. No difference in MS/BS due to age was detected. MAR was shown
to be 3.4 µm/day in iOsx-Ai9 5 mo mice, while iDmp1-Ai9 mice had MAR of 4.7 µm/day.
These MAR values are more than 1.0 µm/day greater than demonstrated in aged mice presented
here, however the interaction between age and loading was only different in iOsx-Ai9 mice.
Male 5 mo mice were also shown in Chapter 3 to stimulate bone formation at -8 N, but to a
lesser degree compared to female 5 mo mice. iOsx-Ai9 males were stimulated to 38% MS/BS
(p=0.05) and 1.7 MAR (not significant) while iDmp1-Ai9 males were stimulated to 45% MS/BS
and 2.1 µm/day MAR (not significant). Overall, similar degrees of bone formation were
stimulated in 5 mo and 22 mo mice, with the exception of a reduced MAR in 22-mo old iOsxAi9 mice compared to 5-mo iOsx-Ai9.
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Figure 4.2: Dynamic histomorphometry demonstrates loading-induced periosteal bone formation in youngadult and aged female mice. (A) Experimental timeline for dynamic histomorphometry. (B) Representative images
of non-loaded and loaded iOsx-Ai9 and iDmp1-Ai9 tibias for both ages. (C-F) Quantification of periosteal
mineralizing surface (Ps. MS/BS) for (C) iOsx-Ai9 and (D) iDmp1-Ai9 and mineral apposition rate (Ps. MAR) for
(E) iOsx-Ai9 and (F) iDmp1-Ai9. Fractions in bars represent woven incidence. Data for 5 mo mice also shown in
Chapter 3. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 by Two-Way ANOVA repeated measures, Sidak
multiple comparisons correction (Factors: Loading, Age).
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The percentage of periosteal bone surface with calcein label was measured in longitudinal
sections used for lineage tracing to quantify degree and type of bone formation (Figure 4.3).
Similar percentages of bone surface were labelled by calcein in 5 mo and 22 mo female mice of
both iOsx-Ai9 (5 mo, 91%; 22 mo, 88%) and iDmp1-Ai9 (5 mo, 98%; 22 mo, 97%). Low
incidence of woven bone occurrence was observed, with iDmp1-Ai9 females having the highest
incidence (3/9). Compared to females, male 5 mo mice had less calcein surface (iOsx-Ai9 39%,
iDmp1-Ai9 64%).
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Figure 4.3: The loading protocol induced bone formation in the ROI as measured by percentage of periosteal
bone surface labeled with calcein. (A) Lineage tracing experimental timeline. (B-C) Calcein surface in female (B)
iOsx-Ai9 (5mo n=8, 22mo n=11) and (C) iDmp1-Ai9 (5mo n=8, 22mo n=9) mice. (D-E) Calcein surface in male
(D) iOsx-Ai9 (n=8) and (E) iDmp1-Ai9 (n=9) mice. Fractions in bars indicate woven bone incidence. *p<0.05,
**p<0.01, ***p<0.001, ****p<0.0001 by Two-Way ANOVA repeated measures, Sidak multiple comparisons
correction (Factors: Loading, Age) or paired t-test.

The number of cells per bone surface did not increase with loading, except in 22 mo
iDmp1-Ai9 female mice (Figure 4.4). In these mice, the non-loaded 22 mo limb had fewer cells
(55 cells/mm) compared to the non-loaded 5 mo female mice (64 cells/mm) and increased with
loading to 68 cells/mm). iOsx-Ai9 5mo female mice had 65-66 cells/mm while the 22 mo iOsxAi9 mouse had 60-63 cells/mm in non-loaded and loaded tibias. Males had similar numbers of
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cells compared to female 5 mo mice. Similar trends were observed in the periosteum (cells not
directly on the bone surface). However, more variation was noted in the number of cells in the
periosteum, ranging from 5 cell/mm up to 148 cells/mm in the non-loaded limb. However,
similar to the bone surface cell number, an increase in cell number per bone surface only
occurred in the periosteum of iDmp1-Ai9 22 mo female mice with loading; increasing from 34
cells/mm to 100 cells/mm. Thus, with exception of iDmp1-Ai9 22 mo females which had a
robust anabolic response to loading, loading did not increase bone surface cellularity.
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Figure 4.4: Number of cells increased with loading only in female iDmp1-Ai9 aged mice. (A-D) Number of
cells per bone surface in female (A) iOsx-Ai9 and (B) iDmp1-Ai9 mice, and male (C) iOsx-Ai9 and (D) iDmp1-Ai9
mice. (E-H) Number of cells in the periosteum (not directly on the bone surface) per bone surface in female (E)
iOsx-Ai9 and (F) iDmp1-Ai9 mice, and male (G) iOsx-Ai9 and (H) iDmp1-Ai9 mice. *p<0.05, **p<0.01,
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***p<0.001, ****p<0.0001 by Two-Way ANOVA repeated measures, Sidak multiple comparisons correction
(Factors: Loading, Age) or paired t-test.

4.4.2 The iDmp1-Ai9 Mice Showed Moderate Leakiness, Especially in 22 mo
Mice
A negligible number of cells were TdT+ without tamoxifen administration in iOsx-Ai9
mice (<5 %), whereas TdT expression was found in 12% of bone surface cells of iDmp1-Ai9
female 5 mo mice and 35% of 22 mo mice (Figure 4.5). Considerable variation was also noticed
with TdT expression varying in 5 mo iDmp1-Ai9 female mice from 6 % to 30 % in non-loaded
limbs. A similar percentage of cells were TdT+ in non-loaded limbs of 5 mo iDmp1-Ai9 male
mice (10%) compared to female 5 mo mice. TdT expression on the bone surface did not change
significantly with loading, but age was a significant factor in iDmp1 mice. No TdT+ cells were
identified in Cre- samples.
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Figure 4.5: Leakiness of iOsx-Ai9 and iDmp1-Ai9 mice. (A-D) Representative images of non-loaded (A) iOsxAi9 22 mo, (B) iDmp1-Ai9 5 mo, (C) iDmp1-Ai9 22mo tibias of mice that did not receive tamoxifen, and (D) Cre22 mo (not quantified: 5 mo, n=11; 22 mo, n=8) tibias in mice that did receive tamoxifen. (E-H) Quantification of
TdT expression on the bone surface in female (E) iOsx-Ai9 (5 mo n=4, 22 mo n=3) and (F) iDmp1-Ai9 (5 mo n=6,
22 mo n=5 mice, and 5 mo male (G) iOsx-Ai9 (n=3) and (H) iDmp1-Ai9 (n=6) mice. *p<0.05, **p<0.01,
***p<0.001, ****p<0.0001 by Two-Way ANOVA repeated measures, Sidak multiple comparisons correction
(Factors: Loading, Age) or paired t-test.

4.4.3 The Number of iOsx-Ai9 TdT+ Cells Decreases on the Bone Surface
with Loading in 5 mo But Not 22 mo Mice
Lineage-positive cells were assessed at day 12 after the first loading bout. In non-loaded
limbs of female iOsx-Ai9 mice, the percentage of TdT+ cells on the bone surface was similar in 5
mo and 22 mo mice (63% and 73%, respectively) (Figure 4.6). A decrease in percentage of TdT+
cells occurred with loading in 5 mo (non-loaded 63%, loaded 40%), but not 22 mo mice. Similar
trends occurred in number of TdT+ cells per bone surface with non-loaded limbs having 41-45
cells/mm while loading caused a decrease in 5 mo mice to 26 cells/mm.
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Figure 4.6: A decrease in iOsx-Ai9 TdT+ cells occurs in 5 mo but not 22 mo mice. (A-D) Representative images
of iOsx-Ai9 female (A) 5 mo non-loaded, (B) 5 mo loaded, (C) 22 mo non-loaded and (D) 22 mo loaded tibias. (EF) Quantification of (E) percentage and (F) number of TdT+ cells on the bone surface. *p<0.05, **p<0.01,
***p<0.001, ****p<0.0001 by Two-Way ANOVA repeated measures, Sidak multiple comparisons correction
(Factors: Loading, Age).

4.4.4 The Number of iDmp1-Ai9 TdT+ Cells on the Bone Surface Decreases
with Loading in 5 mo and 22 mo Mice
In iDmp1-Ai9 female mice, 51% and 59% of the non-loaded bone surface was covered in
TdT+ cells in 5 mo and 22 mo mice, respectively (Figure 4.7). A significant decrease occurred at
both ages with loading to 25% in 5 mo mice and 26% in 22 mo mice. Decreases at both ages
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were also found in number of cells per bone surface. Non-loaded limbs had 33 and 32 TdT+
cells/mm on the bone surface in 5 mo and 22 mo mice, respectively, while loading caused a
decrease to 16 and 17 TdT+ cells/mm in 5 mo and 22 mo mice, respectively.

Figure 4.7: A decrease occurs in iDmp1-Ai9 TdT+ cells in mice of both ages. (A-D) Representative images of
iDmp1-Ai9 (A) non-loaded 5 mo, (B) loaded 5 mo, (C) non-loaded 22 mo, and (D) loaded 22 mo tibias. (E-F)
Quantification of (E) percentage and (F) number of TdT+ cells on the bone surface. *p<0.05, **p<0.01, ***p<0.001,
****p<0.0001 by Two-Way ANOVA repeated measures, Sidak multiple comparisons correction (Factors: Loading,
Age).
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4.4.5 The Number of iOsx-Ai9 and iDmp-Ai9 TdT+ Cells Decreases on the
Bone Surface with Loading in 5 mo Male Mice
Male mice exhibited similar changes in lineage cells, but to a lesser degree (Figure 4.8),
compared to female 5 mo mice. Non-loaded limbs of iOsx-Ai9 mice were 61% TdT+ while
loading caused a trend towards a decrease to 51% (p=0.1). This corresponded to 39 TdT+
cells/mm in the non-loaded limb which decreased significantly to 32 TdT+ cells/mm with
loading. In iDmp1-Ai9 mice, only 51% of cells were TdT+ in non-loaded limbs, and loading
caused a significant decrease to 37%. Similarly, 33 TdT+ cells/mm were present on the bone
surface in non-loaded iDmp1-Ai9 limbs, and loading caused a decrease to 23 TdT+ cells/mm.

113

Figure 4.8: TdT expression in male mice decreases with loading. (A-D) Representative images of male (A-B)
iOsx-Ai9 (A) non-loaded and (B) loaded limbs, and (C-D) iDmp1-Ai9 (C) non-loaded and (D) loaded limbs. (E-H)
Quantification of male (E-F) iOsx-Ai9 (E) percentage (F) number of TdT+ cells on the bone surface, and (G-H)
iDmp1-Ai9 (G) percentage and (H) number of TdT+ cells on the bone surface. *p<0.05, **p<0.01, ***p<0.001,
****p<0.0001 by paired t-test.
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4.4.6 22 mo Mice Have a Similar Proliferative Response to Loading
Compared to 5 mo Mice
To label dividing cells, mice were dosed with EdU in their drinking water from the start
of loading (Day 1) until sacrifice (Day 12). Proliferation on the bone surface was similar between
young-adult and aged mice (Figure 4.9, A-D). Loading increased the percentage of EdU+ cells
from 3% to 37% (25 EdU+ cells/mm) and 39% (26 EdU+ cells/mm) in 5 mo and 22 mo mice,
respectively, in iOsx-Ai9 female mice. In iDmp1-Ai9 female mice, loading increased the
percentage of EdU+ cells from 2% to 46% (30 EdU+ cells/mm) and 62% (43 EdU+ cells/mm) in 5
mo and 22 mo mice, respectively.
Although the percentage of cells arising from proliferation was not different with age,
differences were observed in the percentage of TdT+EdU+ cells at the bone surface in female
iOsx-Ai9 mice (Figure 4.9, E-H). While 5 mo iOsx-Ai9 mice did not experience a change in
TdT+EdU+ cell population at the surface, aged mice had a significant increase in TdT+EdU+ cells
with loading from 2% to 24% (16 TdT+EdU+ cells/mm). Slight increases occurred in iDmp1-Ai9
female mice at both ages, from <1% to 8% (5 TdT+EdU+ cells/mm) and 10% (6 TdT+EdU+
cells/mm) in 5 mo and 22 mo mice, respectively. Thus, while loading induced a similar increase
in proliferation of bone surface cells in old and young-adult mice, the proportion of bone surface
cells that arose via proliferation that were also Osx lineage-positive was greater in old mice.
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Figure 4.9: Proliferation on the bone surface was induced by loading to similar degrees in 5 mo and 22 mo
mice. (A-B) Percentage of EdU+ cells in (A) iOsx-Ai9 and (B) iDmp1-Ai9 females. (C-D) Number of EdU+ cells in
(C) iOsx-Ai9 and (D) iDmp1-Ai9 females. (E-F) Percentage of TdT+EdU+ cells in (E) iOsx-Ai9 and (F) iDmp1-Ai9
females. (G-H) Number of TdT+EdU+ cells in (G) iOsx-Ai9 and (H) iDmp1-Ai9 females. *p<0.05, **p<0.01,
***p<0.001, ****p<0.0001 by Two-Way ANOVA repeated measures, Sidak multiple comparisons correction
(Factors: Loading, Age).

Male 5 mo mice exhibited less proliferation, but similar trends compared to female 5 mo
mice (Figure 4.10). A trend towards an increase in EdU+ cells occurred with loading in iOsx-Ai9
males, but increased only to 9% (6 EdU+ cells/mm). More proliferation occurred in iDmp1-Ai9
mice, reaching 19% (12 EdU+ cells/mm) in loaded limbs. Similar to female mice, male iOsx-Ai9
mice showed no change with loading in TdT+EdU+ cells, but a slight increase occurred in
iDmp1-Ai9 mice (loaded; 4%, 3 TdT+EdU+ cells/mm).
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Figure 4.10: On the bone surface, proliferation increased in male 5 mo mice. (A-B) Percentage of EdU+ cells in
male 5 mo (A) iOsx-Ai9 and (B) iDmp1-Ai9 mice. (C-D) Number of EdU+ cells in male 5 mo (C) iOsx-Ai9 and (D)
iDmp1-Ai9 mice. (E-F) Percentage of TdT+EdU+ cells in male 5 mo (E) iOsx-Ai9 and (F) iDmp1-Ai9 mice. (G-H)
Number of TdT+EdU+ cells in male 5 mo (G) iOsx-Ai9 and (H) iDmp1-Ai9 mice. *p<0.05, **p<0.01, ***p<0.001,
****p<0.0001 by paired t-test.

To determine if the increase in TdT+EdU+ cells in 22mo but not 5mo female iOsx-Ai9 mice
was due to an increased capacity for TdT+ cells to proliferate in 22 mo mice, the percentage of
TdT+EdU+ cells per total TdT+ cells was quantified (Figure 4.11, A-D). These results
demonstrated an increase regardless of age. Thus, in iOsx-Ai9 mice, the increase in percentage
of TdT+EdU+ surface cells only in 22 mo mice is likely due to the greater number of TdT+ cells
at the surface in aged mice. As previously shown, these mice did not experience a decrease in
TdT+ cells at the surface with loading, as occurred in the 5 mo mice (Figure 4.6E-F). With
loading, the percentage of TdT+ cells that arose via proliferation following loading was 22% and
34% in 5 mo and 22 mo female iOsx-Ai9 mice. Similar increases were observed in iDmp1-Ai9
female mice; 29% and 39% in 5 mo and 22 mo female iDmp1-Ai9 mice. Males showed less of
an increase in iOsx-Ai9 and iDmp1-Ai9 mice (7% and 15%, respectively). Similar loading
effects were found in the proliferation rate of TdT- cells on the bone surface (Figure 4.11, E-H),
but these cells had higher rates of proliferation. For example, iOsx-Ai9 5 mo females had a 43%
proliferation rate (vs. 22% for TdT+ cells). Similarly, iDmp1-Ai9 5 mo females had a 54 %
proliferation rate (vs. 29% for TdT+ cells).
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Figure 4.11: Proliferation of TdT+ and TdT- cells on the bone surface. (A-D) Proliferation of TdT+ cells in (A)
female iOsx-Ai9, (B) female iDmp1-Ai9, (C) male iOsx-Ai9, and (D) male iDmp1-Ai9 mice. (E-H) Proliferation of
TdT- cells in (E) iOsx-Ai9 female, (F) iDmp1-Ai9 female, (G) iOsx-Ai9 male, and (H) iDmp1-Ai9 male mice.
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 by Two-Way ANOVA repeated measures, Sidak multiple
comparisons correction (Factors: Loading, Age) or paired t-test.

4.4.7 Cells Within New, Loading-Induced Bone are Primarily TdT+ in 5 mo
and 22 mo Mice
In the new bone region of loaded limbs, between the calcein label and bone surface,
approximately 19 and 14 cells/mm were identified in female iOsx-Ai9 5 mo and 22 mo mice,
respectively (Figure 4.12A). A similar number of cells (20 cells/mm) were found in iDmp1-Ai9
female 5 mo mice, with a greater number (57 cells/mm) in 22 mo mice (Figure 4.12B). Fewer
cells were found in male mice (iOsx-Ai9, 5 cells/mm; iDmp1-Ai9, 7 cells/mm) (Figure 4.12CD).
Of the cells in the new bone region, the majority were TdT+ (Figure 4.12E-J). In iOsxAi9 female mice, 85% and 88% of cells were TdT+ in 5 mo and 22 mo mice, respectively (Figure
4.12E). Similarly, 86% of cells in new bone of iDmp1-Ai9 female 5 mo mice were TdT+, while
67% were TdT+ in 22 mo iDmp1-Ai9 mice (Figure 4.12F). Although a lower percentage of TdT+
cells were found in 22 mo iDmp1-Ai9 female mice, the absolute number of TdT+ cells (28 TdT+
cells/mm) was not less (Figure 4.12H). In males, 88% and 95% of new bone cells were TdT+ in
iOsx-Ai9 and iDmp1-Ai9 mice, respectively (Figure 4.12I-J).
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Figure 4.12: The majority of cells incorporated into new bone are TdT+. (A-D) Total number of cells
incorporated into new bone of loaded limbs in (A) female iOsx-Ai9 and (B) female iDmp1-Ai9, and (C) male iOsxAi9 and (D) male iDmp1-Ai9 mice. (E-F) Percentage of new bone cells in loaded limbs that are TdT+ in (E) iOsxAi9 females and (F) iDmp1-Ai9 females. (G-H) Number of TdT+ cells incorporated into new bone in loaded limbs
per bone surface length in (G) iOsx-Ai9 females and (H) iDmp1-Ai9 females. (I-J) Percentage of new bone cells in
loaded limbs that are TdT+ in (I) male iOsx-Ai9 and (J) male iDmp1-Ai9 mice. *p<0.05, **p<0.01, ***p<0.001,
****p<0.0001 by paired t-test.

4.4.8 In the Periosteum, TdT+ Cells Decrease Only in Aged Mice and
Proliferative Capacity is Unaffected by Age
Interestingly, within the periosteum region above the bone surface, a decrease in
percentage of TdT+ cells with loading occurred in 22 mo but not 5-mo mice (Figure 4.13A-B).
This was observed in female 22 mo iOsx-Ai9 (22% to 5%) and iDmp1-Ai9 (14% to 3%) mice.
The non-loaded 22 mo limb in iOsx-Ai9 female mice had a trend towards an increase in TdT+
cells compared to 5 mo mice at baseline (p=0.06). These pre-existing TdT+ cells in the
periosteum could have been recruited to the bone surface, partially explaining why iOsx-Ai9 22
mo mice had no reduction in TdT+ cells on the bone surface with loading. Similar to the bone
surface, cells within the periosteum of female 22 mo mice proliferated (iOsx-Ai9, 28%; iDmp1Ai9, 55%) to a similar or greater degree in response to loading compared to 5 mo mice (iOsxAi9, 20%; iDmp1-Ai9, 27%) (Figure 4.13E-F). Similar trends were observed in 5 mo male mice
compared to females, but less proliferation was stimulated in loaded limbs (Figure 4.13 C-D, GH).
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Figure 4.13: TdT expression and proliferation in the periosteum. (A-D) Percentage of TdT+ cells in the
periosteum of (A) iOsx-Ai9 females, (B) iDmp1-Ai9 females, (C) iOsx-Ai9 males, and (D) iDmp1-Ai9 males. (EH) Percentage of EdU+ cells in the periosteum of (E) iOsx-Ai9 females, (F) iDmp1-Ai9 females, (G) iOsx-Ai9
males, and (H) iDmp1-Ai9 males. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 by Two-Way ANOVA repeated
measures, Sidak multiple comparisons correction (Factors: Loading, Age) or paired t-test.

4.5 Discussion
The diminished response to loading with age is well established [7], [58], [160], [171],
[172], but the cellular mechanisms contributing to this deficit are still unclear. We show here,
using two transgenic reporters targeting the osteoblast lineage, that pre-existing osteoblasts
(Osx+) continue to sustain the bone formation response in aged mice for 12 days after the
initiation of loading, while earlier precursors contribute more to bone formation at this timepoint
in young-adult mice (Figure 4.14). On the other hand, the role of mature osteoblasts (Dmp1+) in
bone formation was shown to be unaffected by age in this study. Additionally, the ability of cells
to incorporate into new bone was similar with age, where the majority of newly embedded cells
being of Dmp1 lineage. There is substantial evidence that Dmp1 expressing cells play a key role
in mineralization [48], [152], [153], [173], [174], so demonstrating this population has no
impairment with age is an important finding. Lastly, aged mice were shown to have similar
proliferative capacity with loading.
Strikingly, the only difference in the response to loading between 5 mo and 22 mo mice
was in the number of iOsx-Ai9 TdT+ cells at the bone surface following loading. In iOsx-Ai9 5
mo mice, a decrease from 63% to 40% occurred, while the TdT+ population remained constant in
22 mo mice (summarized in Figure 4.14). This difference was not due to fewer cells being
incorporated into new bone. A similar number of iOsx-Ai9 TdT+ cells were incorporated into
new bone in both age groups (5 mo, 19 cells/mm; 14 mo, 11 cells/mm). Within the periosteum,
the non-loaded limbs of iOsx-Ai9 22 mo mice were trending towards a higher number of iOsx125

Ai9 TdT+ cells compared to 5 mo limbs (p=0.06), suggesting a larger pool of osteoblastcommitted cells. Interestingly, in the periosteum of iOsx-Ai9 22 mo mice, we observed a
decrease in percentage of TdT+ cells from 22% in non-loaded limbs to 5% in loaded limbs. No
change occurred with loading in 5 mo mice. These pre-existing Osx lineage cells in the
periosteum may partially replace the cells incorporated into new bone in aged mice. The
resulting composition of the bone surface in iOsx-Ai9 loaded limbs was 70% TdT+ in 22 mo
mice, but only 40% TdT+ in 5 mo mice.
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Figure 4.14: A portion of cells maintaining bone formation by day 12 descend from different origins in 5 mo
and 22mo mice. (A) In young-adult mice, progenitor cells (Osx TdT-) from the periosteum replace pre-osteoblasts
(Osx TdT+) on the bone surface as they incorporate into new bone. (B) More pre-osteoblasts exist in the periosteum
of aged mice and are the primary cells replacing pre-osteoblasts at the surface that incorporated into new bone.
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These age differences in the source of bone surface cells at day 12 were noted in iOsxAi9 but not iDmp1-Ai9 mice, suggesting a greater pool of pre-osteoblasts in aged mice. This
pool of pre-osteoblasts appears to come from the periosteum. Thus, in 5 mo mice, the
differentiation of more progenitor cells (iOsx-Ai9 TdT-) seems to occur compared to aged mice
where pre-osteoblasts are a greater source of cells. Others have reported the importance of
progenitor cells, such as Prx1+ cells, in bone formation [34], [143] and their decreased number
with age [7]. The slightly more committed cells within the periosteum of aged mice replace those
that are incorporated into new bone might affect the ability of aged mice to sustain bone
formation. This supports Holguin and colleagues’ work showing an impairment in sustained Sost
downregulation and Wnt signaling in aged mice [81].
Others have reported greater age deficits in bone formation than we detected in this study
[7], [58], [160], [171], [172]. Our results showed no reduction in periosteal MS/BS, suggesting
no deficit in active osteoblast number. However, we did find a decreased response in periosteal
MAR by about 1 µm/day in aged iOsx-Ai9 mice, suggesting a deficit in cellular activity. No
difference with age was detected in iDmp1-Ai9 mice, which might have been due to the higher
force (-11.5 N) required to generate similar strains in these mice. Our lineage tracing data
support the dynamic histomorphometry results by showing no differences with age in calcein
label, number of cells at the bone surface, or proliferation. The only difference with age that was
detected by our lineage tracing outcomes was a greater number of iOsx-Ai9 TdT+ cells sustaining
the bone formation response at day 12 in aged versus young-adult mice. Thus, these Osx lineage
cells may lead to slower rates of bone formation.
Proliferation was not affected by age in this work, supporting findings by others with
similar techniques for continuous labeling of proliferating cells [1], [80], [149]. However,
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Cabahug-Zuckerman et al. found a decrease in the proliferative response after 2 or 4 days of
loading in aged versus young mice [7], and Meakin et al. demonstrated proliferative deficits in
aged mice in response to mechanical strain in vitro. We did not investigate labeling for shorter
time periods or a shorter loading protocol, but there could be differences in timing of
proliferation between young and aged mice. In fact, our identification of more pre-osteoblasts in
the periosteum of aged mice might support a decreased proliferative capacity at later timepoints
since iOsx-Ai9 TdT+ cells, as shown here, proliferate at a slower rate (5mo, 22%) compared to
iOsx-Ai9 TdT- cells (5mo, 43%) (Figure 4.11A,E). Additionally, we expect differences across
studies in bone formation response and proliferation of young versus aged mice may be due to
differences in level of stimulation applied to the young and aged mice. In our study using
transgenic reporter mice that were housed in our institution’s mouse barrier facility, aged bones
were stiffer and required a higher force to match the strain stimulus of young mice. Notably, this
differs from published findings by us and others that aged C57Bl/6 female mice were slightly
less stiff than young-adults [94], [160], [171]. Using a higher force (but equal estimated strain),
we observed that aged mice were able to form similar amounts of bone as young-adults.
Another important finding from this work was the demonstration of Dmp1 Cre leakiness
in adult mice. We showed that aged mice had over twice as many TdT+ cells on the bone surface
in non-loaded limbs without tamoxifen administration compared to young-adult mice. Although
not shown here, we observed greater leakiness in osteocytes compared to surface cells. Dmp1 is
expressed higher in the intracortical bone compartment compared to more heterogeneous
samples of bone [69], consistent with higher expression in osteocytes. Greater leakiness of the
Dmp1 Cre compared to Osx might be due to relative abundance of expression of Dmp1
compared to Osx. Very high Dmp1-expressing osteocytes, and some osteoblasts, may cause Cre
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leakiness into the nucleus and recombination; these cells would naturally accumulate over time
in aged mice.
Kim et al. showed that Dmp1 is expressed by bone lining cells and that these cells are
activated upon sclerostin antibody treatment [17]. Our results from iDmp1-Ai9 5 mo mice show
86% of cells incorporated into new bone are of Dmp1 lineage, suggesting a predisposition for
these cells to embed. It is likely that these cells contributed to early bone formation, supporting
the role for Dmp1 cells in bone formation. These results also support the role of Dmp1
expressing cells in mineralization [48], [152], [153], [173].
While this work was able show many mechanisms in aged mice are not impaired, we did
find some differences with age in types of cells contributing to the maintenance of bone
formation out to 12 days. However, we were only able to examine the periosteal surface due to
sectioning artifacts and difficulty distinguishing osteoblasts from marrow cells on the endosteal
surface (Figure 4.15). We expect differences between these compartments due to the cellular
population surrounding the surface cells that are able to respond and sustain bone formation.
Turner et al. showed large differences in proliferative response to loading in the periosteal (90%)
and endosteal (30-40%) compartment, although this might be caused by use of 4-point bending
contacts on the periosteal surface [148]. Cabahug-Zuckerman et al. also found differences in
these surfaces, showing the endosteal surface proliferative response is delayed by 2 days relative
to the periosteal compartment [7]. Finally, Birkhold et al. importantly showed that the
responsiveness of the periosteal surface of aged mice declines faster than the endosteal surface
[172].

130

Figure 4.15: The endocortical surface was challenging to analyze. (A-H) Images of the endocortical surface for
(A-B) iOsx-Ai9 5 mo, (C-D) iOsx-Ai9 22 mo, (E-F) iDmp1-Ai9 5 mo, and (G-H) iDmp1-Ai9 22mo non-loaded
and loaded limbs. Some cells are clearly endocortical surface cells (yellow arrow), while others are difficult to
distinguish from marrow cells (green arrow), and in some cases separation of the endocortical surface from the
marrow tissue occurred (white arrow).

Additional knowledge would also be gained by examining the surface cells at even longer
timepoints following loading stimulation. Whether or not the pre-marked lineage positive cells
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continue to reside on the surface or if progenitor cells completely resupply surface cells is an
interesting question that we were not able to address with this time point. Furthermore, the force
level could have been increased to speed up the process and examine this question. However, the
forces chosen here were close to the threshold for woven bone formation, especially in iDmp1Ai9 22 mo females (-11.5 N) where 3 of 9 samples experienced woven bone.
The results presented here show that, under similar degrees of loading-induced bone
formation, there were many similarities in cellular source for loading induced bone formation in
young-adult and aged mice. We found similar contribution of Dmp1 lineage cells to bone
formation and incorporation into new bone regardless of age. We also demonstrated similar
levels of proliferation in young-adult and aged mice following loading. However, a difference in
the pre-osteoblast lineage at the surface following loading was identified in young versus aged
mice, revealing a potential mechanism for diminished ability to sustain bone formation in aged
mice. Future work should continue to address the timing of proliferation in young and aged mice,
the location of these pre-existing TdT+ cells at longer time periods following loading, and
differences on the endosteal surface.
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5Chapter 5: Conclusions and Future
Directions
5.1 Conclusions
A better understanding of mechanical loading induced bone formation, from
mechanosensation to the initiation and sustainment of bone formation, could drive discovery of
new anabolic therapies for osteoporosis. Current unknowns in bone mechanobiology include the
molecular signals for communication between osteocytes and osteoblasts, and the roles of
differentiation and proliferation in osteoblasts during active bone formation. This dissertation
begins to address these unknowns by discovering osteocyte-specific genes expressed in response
to loading, and the contribution of Osx and Dmp1 lineage cells to bone formation as well as their
proliferative capacity. Importantly, we also investigate these mechanisms for loading induced
bone formation in aged mice to reveal any deficiencies that may occur with age.
Osteocytes are embedded in mineralized bone, making them challenging to study. Methods
for isolating osteocytes include collagenase treatment which degrades bone mineral and other
cells until an osteocyte-enriched population remains [11], [175], or use of lineage reporter mice
and fluorescence activated cell sorting (FACS) to isolate cells expressing only a specific factor.
However, collagenase treatment and cell sorting can affect gene expression [176] because of the
molecular and physical environment the cells are placed in, and yields for these techniques can
be very low, especially with older mice [11]. Additionally, reporter mice specific to osteocytes
alone have not been developed. Laser capture microdissection (LCM) has allowed the isolation
of specific regions from histological sections for a more homogeneous cell population. LCM has
been used by others [65], [87], but has not been used to study osteocyte specific gene expression
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following loading induced bone formation in mice. Thus, our goal was to utilize this method to
determine genes expressed by osteocytes at a mechanosensitive (4 hr) and bone forming (day 5)
timepoint.
We found a robust increase in Ngf following loading at both timepoints in osteocyteenriched intracortical bone (Intra-CB). Others have identified a role for Ngf in loading induced
bone formation, but not in osteocytes [85]. We were also able to confirm the expression of Ngf in
some osteocytes within Intra-CB using in situ hybridization. These results could be important,
especially since Tomlinson et al. showed Ngf signaling appears to be upstream of Wnt signaling
in osteocytes [85].
Our analysis of intracortical bone also allowed the identification of osteocyte-driven
upregulation of Wnt1 in response to loading. This gene has been proposed as a signaling
molecule by others [138] and may trigger Wnt signaling in surface cells. Wnt signaling increases
osteoblast activity and proliferation in osteoblasts [177], [178]. Thus, Wnt1 could be one of the
critical signaling molecules between osteocytes and osteoblasts during loading induced bone
formation. Not only was Wnt1 upregulated (1.5-fold) at an early timepoint following loading (4
hours), but the loading effect was accentuated on day 5 (5.1-fold). Only two genes in common
between day 1 and day 5 were upregulated more on day 5 compared to day 1 (Wnt1, Inhba);
thus, Wnt1 could be essential for sustaining the bone formation response for longer periods.
However, before investigating the effects of Wnt1 on osteoblasts during loading induced bone
formation, a clear understanding of osteoblast differentiation, activation, and proliferation during
loading is essential. Thus, this dissertation further investigated the downstream effects of
osteocyte signaling, focusing on osteoblast differentiation and proliferation.
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The importance of osteoprogenitors for bone formation following loading on day 15 has
been demonstrated [143], while others have shown that more differentiated, Osx lineage cells are
the primary cells contributing to bone formation on day 5 of loading [1]. We sought to establish
the role of Osx-expressing, and fully differentiated Dmp1-expressing cells to the initiation (day
8), and the sustainment of bone formation (day 12). Proliferation has also been shown to be
important with loading [149], and some have shown proliferation to be affected by age [7],
[160]. However, others have shown that proliferation is unaffected by age [80]. Thus, we also
evaluated the role of proliferation at day 8 and 12 in both young-adult and aged mice.
This dissertation showed that Osx and Dmp1 lineage cells are activated following loading
and contribute significantly to bone formation. We extended work by Zannit et al. showing the
importance of Osx lineage cells by demonstrating that the majority of the response is driven by
more mature, Dmp1-expressing cells [1]. Moreover, this source of cells is nearly depleted from
the surface by day 8 following robust levels of bone formation and are replaced by non-lineage
cells, presumably osteoprogenitors. Thus, the role of osteoprogenitor cells may be in sustaining
the bone formation response. Wnt1 and other signaling molecules might orchestrate the
activation of Dmp1 cells at the surface and/or stimulate the proliferation of these cells. That
Wnt1 is upregulated more on day 5 also suggests a potential role in influencing the proliferation
and differentiation of non-lineage cells within the adjacent periosteum which appear to be
essential at later timepoints for sustaining bone formation.
Lastly, through our lineage tracing experiments in young and aged mice, we showed that
aged mice utilize similar mechanisms for loading induced bone formation and can be stimulated
to respond to loading to a similar extent compared to young adult mice. One difference we
identified was in the differentiation stage of osteoblasts within the periosteum that appear to
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replace bone surface cells as they embed. Aged mice had slightly more Osx+ cells in non-loaded
limbs compared to young mice, and the population of these cells in the periosteum decreased
with loading in aged mice. We showed Osx+ cells are capable of dividing, but at a slower rate
compared to Osx- cells. Thus, downstream aging effects might occur in proliferative response at
later timepoints following loading, or potentially with more robust levels of bone formation
where the bone surface cells are depleted more rapidly.
Our findings show, for the first time, Ngf and Wnt1 expression by osteocytes following
loading induced bone formation. Both of these molecules have been shown to be important to
bone mechanoresponsiveness [81], [85], [138], but their expression by osteocytes specifically
has not been established. Whereas the role of Ngf is less clear, Wnt signaling has been well
studied in osteoblasts, and has been shown to increase osteoblast number and activity [177],
[178]. This dissertation shows that downstream effects of mechanotransduction include
activation of Dmp1-expressing cells at the bone surface to initiate bone formation, embedding of
these cells after bone formation occurs, and subsequent replacement of these cells by previously
less differentiated (Osx-) cells that appear to sustain the bone formation response. Finally, we
showed remarkable similarity between young-adult and aged mice in mechanoresponsiveness,
with aged mice experiencing comparable levels of bone formation and proliferative capacity. A
potentially more differentiated cell population in the periosteum of aged mice suggests this
should be an area of future investigation.

5.2 Future Directions
Utilizing LCM to obtain an osteocyte-enriched tissue from bone allowed us to discover
potential cell-signaling molecules expressed by osteocytes following loading. However, the
LCM technique has many challenges. The laser thickness and power required to isolate bone
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regions prevented us from being able to compare the osteocyte-enriched population to other bone
cell types like osteoblasts or more generally periosteal cells. Additionally, the low yield and
quality of RNA that resulted from microdissected samples prevented us from using RNAseq
which is more robust than microarray. Another LCM technique that collects the tissue specimen
via partial melting of a collection cap which allows attachment of the tissue, is gentler on cells,
and enables isolation of single cells from tissue sections may be considered for future bone
studies. Other methods besides LCM could also be refined. NuTrap mice allow for the isolation
of ribosomes, and attached mRNA from specific cells determined by the Cre line used [179]. But
efforts in our lab to apply this technique to bone have not been successful. We also show here
that the inducible Dmp1 cre without tamoxifen is primarily an osteocyte reporter, with only
approximately 10% of cells on the surface expressing Dmp1 in 5 mo mice. Thus, this mouse
combined with cell sorting could be utilized to enrich for osteocytes. Traditional whole bone
processing could also be modified with the addition of scraping of the periosteum to improve
osteocyte-enrichment. Finally, single cell RNAseq methods have been improving and could be
used to better study osteocyte mechanotransduction [101]. These methods, and more use of in
situ hybridization will improve the literature on osteocyte specific gene expression. Besides these
technical aspects, studies should compare the transcriptomics of osteocytes in young and aged
mice following loading.
Lineage tracing with the inducible Osx and Dmp1 reporters allowed us to demonstrate that
mature Dmp1-expressing cells make significant contributions to bone formation, whereas the
Osx+ preosteoblast cell type represents a small portion of osteoblast cells on the bone surface.
However, we also showed that lineage-negative cells contributed significantly to the bone
surface after 8 days of robust bone formation and following 12 days of lamellar bone formation.
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Thus, future work should focus on the cells necessary to sustain the bone formation response.
Inducible reporter mice that mark cells earlier in the lineage, like Prx1-Cre [143], could be used
to investigate the role of osteoprogenitors in loading induced bone formation.
We showed that aged mice appear to have a slightly larger preosteoblast population in the
periosteum compared to young-adult mice. These cells replace bone surface cells after the latter
have embedded, and thus seem to sustain the bone formation response. Whether these cells have
a reduced capacity to form bone at later timepoints or after subsequent loading stimulus would
be an interesting question to address.
We demonstrated that a comparable proliferative capacity exists in young adult and aged
mice following loading. To further investigate proliferation, the window of EdU administration
could be shortened and delivered only in the first few days of loading, during the middle of the
loading experiment, and at the end of the experiment to elucidate any differences in timing of
proliferation with age.
Lastly, this dissertation indicated a potential role of Wnt1 as an osteocyte-expressed
signaling molecule to osteoblasts. Future studies should further investigate the role of Wnt1 in
bone, especially how it is transported to osteoblasts, and how it effects differentiation, activation,
and proliferation of osteoblast cells. Although the inducible Sost-Cre has a phenotype with age
[68], it would be interesting to knock out Wnt1 in this mouse model to primarily target
osteocytes and investigate the effect on osteoblasts at the surface following loading.
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Appendix A – Osx-Expressing Cells in
Fracture Repair of Young-Adult and Aged
Mice
A.1 Introduction
To strain match 22 mo male iOsx mice to 5 mo mice, a peak force of -16 N was required.
This force is likely to induce damage to soft tissue. Pathways stimulated by damage would cause
many effects unassociated with physiological loading-induced bone formation which was the
focus of this dissertation. Instead of loading 22 mo iOsx males to understand the role of Osxexpressing cells in lamellar bone formation, we used these mice to investigate the role of Osxexpressing cells in fracture repair. Buettmann et al. showed that Osx-expressing cells were
important for periosteal bone formation and angiogenesis during fracture repair [180].
Additionally, reduced vascular density has been associated with delayed healing in aged mice
[181]. Thus, we hypothesized that pre-existing Osx-expressing cells are less abundant in the
fracture callus of aged mice compared to young-adult mice. Furthermore, the role of proliferation
in aged mice is unclear. Lopas et al. showed no difference in proliferation in the bony region of
the callus by PCNA staining [182]. However, Yukata et al. showed no difference in number or
percentage of proliferating cells by PCNA staining, but noted differences in gene expression and
thickness of the periosteum in young versus aged mice [183]. Thus, our continuous EdU
administration protocol represented an improved method for detecting the degree of proliferation
in aged versus young-adult mice in the context of fracture healing.
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A.2 Methods
A.2.1 Fracture Experiments
Osx-Cre-ERT2;Ai9 mice were dosed with tamoxifen (75mg/kg) for 5 days followed by a
3 week clearance before performing complete (full) fracture at the mid-diaphysis of the femur as
described elsewhere [184]. For some mice, instead of a 24 gauge wire for stabilizing the femur, a
23 or 21 gauge needle was used due to the larger medullary cavity of 22 mo mice. X-ray images
were obtained of the femur to detect distal fractures. Mice were allowed free cage activity
following fracture. EdU was delivered to the mice via their drinking water (0.2 mg/ml EdU, 5%
sucrose) to label any cells arising via proliferation. Sacrifice occurred on day 14 following
fracture. 28 mice were fractured. Three (3) were sacrificed due to poor fracture or health decline.
Seven (7) of the remaining 25 mice had distal fractures.

A.2.2 Histology
Fractured femurs, and contralateral controls were fixed in PFA (4%) overnight. Next,
femurs were decalcified for 14 days in 14% EDTA, with fresh EDTA changed approximately 3
times per week. Bones were washed in PBS 3x and soaked in 30% sucrose for 2 days. OCT
infiltration occurred for 1 day followed by embedding in OCT. Frozen, undecalcified
cryosections (5-µm thick) were obtained using CryoJane sectioning materials (Leica). Femur
sections were subsequently stained for EdU per manufacturer’s instructions and counterstained
with DAPI. Images of the section were acquired on a Zeiss slide scanner with filters for DAPI,
DS-Red, and Far-Red.
Of the 18 mice with mid-point fractures (12 Cre+, 2 Cre-, 4 Cre+ w/o TAM), 2 were not
analyzed due to histological artifacts. A total of 11 Cre+ TAM samples (5 mo, n=3; 22mo, n=8)
were obtained, 2 Cre- TAM samples (5 mo, n=1; 22 mo, n=1), and 3 Cre+ No TAM (5 mo, n=2;
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22 mo, n=1). Within each of the callus regions, the 4 corners of the callus were observed. Some
regions were too blurry, or histological artifacts were present; thus, some of these callus subregions were not analyzed. Regions were qualitatively assessed. A score between 1 and 5 was
given for degree of TdT or EdU within the callus sub-regions; with 1 being the least amount, and
5 being the greatest.

A.3 Results
Qualitative assessment of abundance of TdT and EdU in callus sub-regions showed a
greater average score for TdT abundance in 22 mo mice, and a lower score for EdU abundance in
22 mo mice (Table 3). However, only three 5 mo mice were included in this assessment, and
statistics were not performed to determine significance since too few samples were analyzed.
Representative images of 5 mo and 22 mo samples are shown in Figure A.1. Without tamoxifen
administration, expression of TdT was very low in the fracture callus of 5 mo and 22 mo mice
(Figure A.2).
Table 3: Average scores for abundance of TdT and EdU for 5 mo and 22 mo callus regions

5 mo
22 mo

TdT
1.7
2.4

EdU
5
3.6
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# mice
3
9

# regions
3
31

Figure A.1: Representative images of day 14 fracture callus sub-regions for (A) 5 mo and (B) 22 mo iOsx
mice. Red=TdT, White=EdU, Blue=Dapi.
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Figure A.2: Representative images of day 14 fracture callus sub-regions for (A) 5 mo and (B) 22 mo iOsx mice
without tamoxifen, and (C) Cre- mice with tamoxifen. Red=TdT, White=EdU, Blue=Dapi.

A.4 Conclusions
Our preliminary results comparing young-adult and aged fracture healing in mice show
that there may be some differences in the recruitment of Osx-expressing cells and in proliferative
capacity, but the difference is not large, if one exists. Contrary to our hypothesis, on average,
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more pre-existing Osx-expressing cells were recruited to the callus region in 22 mo compared to
5 mo mice. However, in support of our hypothesis, preliminary qualitative assessment suggests a
slight reduction in cells arising via proliferation in the callus. Further investigation is needed to
determine the functional activity of these cells, and if they cells contribute to a reduction in
healing capacity.
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Appendix B – Inducible Osteocalcin Cre
Reporter Mouse
B.1 Introduction
The Osteocalcin (Ocn) Cre-ERT2;Ai9 inducible reporter mouse marks cells beginning at
the mature osteoblast stage. Expression in the Ocn-Cre-ERT2 mouse has been found in the
periosteum, cortical bone, and endosteum of 10 week old mice [17], [64]. Thus, in order to mark
mature osteoblasts in our lineage tracing experiments, we evaluated the expression of this
reporter mouse in the tibia.

B.2 Methods
The Ocn-Cre-ERT2 (iOcn) mouse were generously given to us by Henry Kronenberg.
We crossed the iOcn mouse to the TdT/Ai9 reporter (#007909, The Jackson Laboratory). We
attempted several methods for tamoxifen administration to label cells, including: continuous
chow for 2 weeks, 1 injection + 2 day clearance, 1 week (5 days) injection + 1 week clearance,
gavage and intraperitoneal injections. We also examined expression in fracture callus, as well as
different ages: 6, 10, 12, and 16 weeks. Frozen undecalcified sections were obtained for analysis.
For fractured limbs, partially decalcified sections were obtained with CryoJane sectioning
materials.

B.3 Results
Despite dosing mice with tamoxifen in different ways (i.p., gavage, chow) at different
doses and with different clearance periods, in addition to evaluating mice at a variety of ages and
in the context of fracture healing, we observed modest expression of osteocalcin in bone (Figure
B.1). The greatest expression was found on the endosteal surface of either 6 week old mice dosed
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once with tamoxifen with a 2 day chase, or in 18 week old mice dosed with 100 mg/kg of
tamoxifen by gavage daily for 1 week followed by a 1 week clearance. However, even in these
instances, endosteal osteoblast expression was inconsistent along the surface of either tibias or
femurs, minimal expression occurred in osteocytes, and periosteal osteoblasts were rarely
labeled.

Figure B.1: Expression of Ocn-Cre-ERT2;Ai9 reporter. (A) Femur of 12 week old mouse with 2 weeks of
continuous TAM chow. (B) Tibia of 6 week old mouse with 1mg i.p. TAM injection and 2 day clearance. (C) Tibia
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of 18 week old mouse with 100 mg/kg Tamoxifen by gavage daily for 1 week followed by 1 week of clearance. (D)
Femoral fracture callus of 14 week old mouse with 100 mg/kg Tamoxifen by gavage daily for 1 week followed by 1
week of clearance, fracture, and 10 days of healing. Red=TdT, Blue=Dapi.

B.4 Conclusions
We found limited expression of Ocn in the tibia and femur using the Ocn-Cre-ERT2;Ai9
reporter mouse. Osteoblasts on the periosteal surface were rarely labeled, even in young mice. In
our lineage tracing experiments, we are interested in quantifying cells that are contributing to
bone formation on the periosteal surface, thus this osteoblast reporter mouse was not useful for
addressing our questions. Our next steps were to evaluate other mature osteoblast reporters.
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Appendix C – Methods for Sectioning
Undecalcified Bone
C.1 Bone Sectioning Methods and Tools
Several methods exist for sectioning bone including paraffin sectioning and frozen
sectioning (no film, CyroJane tape transfer system, Kawamoto film). Sectioning bone can bring
many challenges, especially when the tissue is not fully decalcified, including issues with the
tissue not adhering to the slide (and remaining on slide during staining), the tissue section
wrinkling upon sectioning, transferring the tissue from the tape to the slide (CryoJane), and
achieving a flat section for staining and imaging. The following section will cover some basics
and tips for successful sectioning of bone.
Paraffin sectioning can only be done in bone with fully decalcified tissue. For optimal
decalcification of skeletally mature mouse bone (5 mo to 22 mo), 2 weeks of infiltration with
14% EDTA (changing every other day) is required. Some difficulty with sectioning bone in
paraffin includes keeping the section adhered to the slide, especially during staining procedures.
Specially designed glass slides have been developed to improve this problem. The Superfrost
Plus microscope slides (Fisher Scientific) have been recommended. If problems persist, glue
(Elmers) can be added to the water bath to help with adhesion. Baking the slides overnight at
60°C has been a common procedure for improving adhesion of paraffin bone sections.
Additional baking steps before staining can also help prevent tissue detachment.
Paraffin is known to have autofluorescence, and thus is not the best choice for any
fluorescent reporters or staining with fluorophores. If calcein is not of interest, bone can be
decalcified and sectioned using CryoJane Tape Transfer System or Kawamoto Film. For these
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techniques, bones are sectioned in a cryostat and they need to be soaked in Optimal Cutting
Temperature (OCT) medium and embedded in OCT prior to sectioning. The CryoJane Tape
Transfer System uses a tape that aides in obtaining a flat, unwrinkled section from a bone block.
Then, the tape (with tissue adhered) is rolled (tissue face-down) onto a special slide with an
adhesive coating. Pressure is applied to encourage the tissue to be transferred from the tape to the
slide. Finally, a UV pulse is applied to the slide and tape to complete the transfer process.
Ideally, the tape is peeled away and the tissue remains on the slide. However, challenges are
presented with the transfer system, and oftentimes all the tissue doesn’t transfer and tissue
remains stuck to the tape. If problems persist, better control of the temperature of the slide, tissue
and tape can help, more pressure can be applied when rolling the tape onto the slide, and more
UV pulses can be attempted.
For undecalcified sections, which is only recommended if calcein is required in the
section, the Kawamoto film technique appears to be the best option. This film is applied to the
frozen block similarly to the CryoJane tape. However, instead of transferring the tissue to the
slide, the tissue remains on the film. Initially, the ends of the film are glued to the slide. Then,
chitosan adhesive is applied to the slide, the tape (tissue face-up) is placed on the chitosan and
allowed to wick to kimwipes for 2 days at 4°C. The wicking process is important to allow the
film to become as flat as possible. Undecalcified bone will result in more uneven tissue sections
which makes imaging the entire bone difficult since multiple focal points will be needed along
the length of the bone. Wicking helps straighten the film and tissue for better imaging.
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C.2 Obtaining the Correct Longitudinal Plane for Analysis
of Maximal Compressive Surface in the Mouse Tibia
One challenging aspect of sectioning bone is obtaining the correct plane of interest. First,
transverse or longitudinal sections can be chosen. Choosing the correct orientation will depend
on the outcome of interest. For studying loading effects on surface cells, longitudinal sections
might represent the best option. The maximal compressive surface occurs on the postero-lateral
apex (PL) where maximal strain and loading effect will occur (Figure C.1) [94]. On the opposite
side of the bone, the antero-medial (AM) surface, maximal tensile strain occurs which can
experience about half the strain occurring on the PL apex. Between these sites is a neutral axis
where loading effects are minimal. Patel et al. showed that the strain gradient along the length of
the tibia is fairly consistent [94]. Thus, when analyzing a region like the bone surface cells where
only a thin layer of cells resides, choosing a longitudinal section will allow more cells to be
quantified that are experiencing a similar, maximal strain along the length of the tibia. A
transverse section would limit the number of cells within the maximal compressive region to be
quantified. One advantage of the transverse sections is that the maximal compressive surface is
easily identified in any section due to the shape of the bone, but longitudinal sections require
more experience sectioning to obtain the correction plane of interest. The following section
reviews some steps and techniques for achieving the correct longitudinal plane for analyzing the
maximal compressive surface of the tibia. CT images and images of a bone being actively
sectioned on a cryostat will aide in visualization of the process.
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Figure C.1: Strains experienced by the tibia of a 5 mo mouse. (A) Tibia model of strain gradients throughout the
bone. (B) Transverse plane of 5 mo mouse tibia 5 mm proximal to the tibial plateau with maximal compressive (PL)
and tensile (AM) surfaces identified. The black line represents the location through which the longitudinal section
(perpendicular to the page) should pass to capture the maximal compressive region. Images adapted from Patel et al.

To obtain a longitudinal section through the maximal compressive surface of the tibia, the
bone needs to be embedded with the tibial wing and fibula face-down. The easiest way to ensure
this occurs is to trim the muscle so that a flat plane with the fibula and wing in the same surface
can be achieved and the bone can be laid down on that surface. Figure C.2 shows the sectioning
face of the tibia when cutting begins if the tibial wing and fibula were embedded face-down. As
sectioning progresses, the metaphysis and distal ends of the tibia come into view first. Care
should be taken to make sure the block is not tilted too far to the fibula, as the fibula should
remain in view throughout the sectioning to ensure proper plane is obtained. The tensile surface
will become visible, with thicker bone developing distally first.
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Figure C.2: Progression of sectioning through tibia. (A) Embed tibia with wing and fibula down, in the same
plane. Blue line illustrates plane of section (into the page). Initial longitudinal sections will have some metaphysis,
proximal fibula, and the beginning of the tensile surface coming into view. (B) As sectioning progresses through the
bone, more of the fibula appears along with more of the tensile surface. (C) Example of the metaphysis, fibula, and
tensile surface coming into view of the sectioning plate during cryo-sectioning.

Sectioning further into the bone, both cortices of the distal tibia will come into view, and
more of the fibula will be visible (Figure C.3). Finally, the correct plane will be achieved when a
thick compressive cortex is visible, and a thin region of marrow is visible between the
compressive and tensile cortex on the proximal end of the tibia. Again, the fibula should still be
visible and not cut through; thus, the block is more often tilted towards the tensile side when
orienting the bone.
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Figure C.3: Progression of sectioning through tibia. (A) As sectioning continues, both cortices of the distal tibia
will come into view before the proximal tibia’s cortices. (B) The optimal plane will be reached when the proximal
bone has thick cortical bone with a thin layer of marrow apparent. The fibula should still be in view. (C) The
transverse planes of the proximal tibia and ~5 mm proximal to the tibiofibular junction.

C.3 Troubleshooting
We have also observed some inconsistency in fixation along the length of the tibia which
appears to be improved by cutting the proximal and distal ends of the tibia and removing as
much muscle as possible so that the fixative is able to reach all compartments of the bone evenly.
However, removing too much muscle can result in the periosteum being peeled from the bone. If
no DAPI is visible on the periosteal bone surface, then the periosteum has been ripped away
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from the bone. The ideal section will have some muscle so that the start and end of the
periosteum can be distinguished. Another potential issue is calcein being washed out of the bone,
which might pose a problem when more muscle is cut away and if bones are left in PBS or other
aqueous solution for too long. It is recommended to make sure calcein remains in the tissue of
interest using the protocol in question before starting a study, and to stay consistent with a
dissecting technique throughout the experiment for all samples.
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